Endocrine-Related Cancer
Journal Impact IF - Analysis · Trend · Prediction · Ranking


Journal Impact IF




Journal Impact IF Trend

Related Journals

Popular Journals

Endocrine-Related Cancer

The 2019-2020 Journal Impact IF of Endocrine-Related Cancer is 4.8, which is just updated in 2020.

Endocrine-Related Cancer Impact Factor
Highest IF
Highest Journal Impact IF

The highest Journal Impact IF of Endocrine-Related Cancer is 5.331.

Lowest IF
Lowest Journal Impact IF

The lowest Journal Impact IF of Endocrine-Related Cancer is 4.364.

Total Growth Rate
IF Total Growth Rate

The total growth rate of Endocrine-Related Cancer IF is 10.0%.

Annual Growth Rate
IF Annual Growth Rate

The annual growth rate of Endocrine-Related Cancer IF is 1.1%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Oncology Q1 48/331

Oncology 85%

Cancer Research Q1 40/198

Cancer Research 80%

Endocrinology Q1 16/118

Endocrinology 86%

Endocrinology, Diabetes and Metabolism Q1 24/217

Endocrinology, Diabetes and Metabolism 89%

Journal Impact IF Ranking

· In the Oncology research field, the Quartile of Endocrine-Related Cancer is Q1. Endocrine-Related Cancer has been ranked #48 over 331 related journals in the Oncology research category. The ranking percentile of Endocrine-Related Cancer is around 85% in the field of Oncology.
· In the Cancer Research research field, the Quartile of Endocrine-Related Cancer is Q1. Endocrine-Related Cancer has been ranked #40 over 198 related journals in the Cancer Research research category. The ranking percentile of Endocrine-Related Cancer is around 80% in the field of Cancer Research.
· In the Endocrinology research field, the Quartile of Endocrine-Related Cancer is Q1. Endocrine-Related Cancer has been ranked #16 over 118 related journals in the Endocrinology research category. The ranking percentile of Endocrine-Related Cancer is around 86% in the field of Endocrinology.
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Endocrine-Related Cancer is Q1. Endocrine-Related Cancer has been ranked #24 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Endocrine-Related Cancer is around 89% in the field of Endocrinology, Diabetes and Metabolism.

Endocrine-Related Cancer Impact Factor 2020-2021 Prediction

Endocrine-Related Cancer Impact Factor Predition System

Endocrine-Related Cancer Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
Total Citations

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 4.8
2018-2019 4.774
2017-2018 5.331
2016-2017 5.267
2015-2016 4.472
2014-2015 4.805
2013-2014 4.907
2012-2013 5.261
2011-2012 4.364
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Endocrine-Related Cancer is 4.8
· The 2018-2019 Journal Impact IF of Endocrine-Related Cancer is 4.774
· The 2017-2018 Journal Impact IF of Endocrine-Related Cancer is 5.331
· The 2016-2017 Journal Impact IF of Endocrine-Related Cancer is 5.267
· The 2015-2016 Journal Impact IF of Endocrine-Related Cancer is 4.472
· The 2014-2015 Journal Impact IF of Endocrine-Related Cancer is 4.805
· The 2013-2014 Journal Impact IF of Endocrine-Related Cancer is 4.907
· The 2012-2013 Journal Impact IF of Endocrine-Related Cancer is 5.261
· The 2011-2012 Journal Impact IF of Endocrine-Related Cancer is 4.364

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1994 16 0
1995 30 15
1996 30 61
1997 49 54
1998 30 116
1999 59 213
2000 19 280
2001 29 674
2002 19 1212
2003 56 1612
2004 64 2079
2005 94 2704
2006 105 3823
2007 92 4622
2008 120 5672
2009 80 6192
2010 129 7335
2011 79 7939
2012 112 9219
2013 122 9686
2014 141 10162
2015 129 10077
2016 147 9853
2017 142 10072
2018 130 8392
2019 116 9041
2020 108 10112
2021 12 704
Publications Cites Dataset

· The Endocrine-Related Cancer has published 16 reports and received 0 citations in 1994.
· The Endocrine-Related Cancer has published 30 reports and received 15 citations in 1995.
· The Endocrine-Related Cancer has published 30 reports and received 61 citations in 1996.
· The Endocrine-Related Cancer has published 49 reports and received 54 citations in 1997.
· The Endocrine-Related Cancer has published 30 reports and received 116 citations in 1998.
· The Endocrine-Related Cancer has published 59 reports and received 213 citations in 1999.
· The Endocrine-Related Cancer has published 19 reports and received 280 citations in 2000.
· The Endocrine-Related Cancer has published 29 reports and received 674 citations in 2001.
· The Endocrine-Related Cancer has published 19 reports and received 1212 citations in 2002.
· The Endocrine-Related Cancer has published 56 reports and received 1612 citations in 2003.
· The Endocrine-Related Cancer has published 64 reports and received 2079 citations in 2004.
· The Endocrine-Related Cancer has published 94 reports and received 2704 citations in 2005.
· The Endocrine-Related Cancer has published 105 reports and received 3823 citations in 2006.
· The Endocrine-Related Cancer has published 92 reports and received 4622 citations in 2007.
· The Endocrine-Related Cancer has published 120 reports and received 5672 citations in 2008.
· The Endocrine-Related Cancer has published 80 reports and received 6192 citations in 2009.
· The Endocrine-Related Cancer has published 129 reports and received 7335 citations in 2010.
· The Endocrine-Related Cancer has published 79 reports and received 7939 citations in 2011.
· The Endocrine-Related Cancer has published 112 reports and received 9219 citations in 2012.
· The Endocrine-Related Cancer has published 122 reports and received 9686 citations in 2013.
· The Endocrine-Related Cancer has published 141 reports and received 10162 citations in 2014.
· The Endocrine-Related Cancer has published 129 reports and received 10077 citations in 2015.
· The Endocrine-Related Cancer has published 147 reports and received 9853 citations in 2016.
· The Endocrine-Related Cancer has published 142 reports and received 10072 citations in 2017.
· The Endocrine-Related Cancer has published 130 reports and received 8392 citations in 2018.
· The Endocrine-Related Cancer has published 116 reports and received 9041 citations in 2019.
· The Endocrine-Related Cancer has published 108 reports and received 10112 citations in 2020.
· The Endocrine-Related Cancer has published 12 reports and received 704 citations in 2021.
· The total publications of Endocrine-Related Cancer is 2259.
· The total citations of Endocrine-Related Cancer is 131921.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Endocrine-Related Cancer | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Endocrine-Related Cancer Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Endocrine-Related Cancer during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Endocrine-Related Cancer.


The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor


  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.


Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Endocrine-Related Cancer
Journal Profile


Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society. Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered. None

Highly Cited Keywords


The ISSN of Endocrine-Related Cancer is 1351-0088 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
ISSN (Online)

The ISSN (Online) of Endocrine-Related Cancer is - . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

BioScientifica Ltd.

Endocrine-Related Cancer is published by BioScientifica Ltd. .

Publication Frequency
Publication Frequency

Endocrine-Related Cancer publishes reports Quarterly .

1994 - Present

The Publication History of Endocrine-Related Cancer covers 1994 - Present .

Open Access
Open Access

Endocrine-Related Cancer is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Endocrine-Related Cancer. Endocrine-Related Cancer is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.


The language of Endocrine-Related Cancer is English .

United Kingdom

The publisher of Endocrine-Related Cancer is BioScientifica Ltd. , which locates in United Kingdom .

Selected Articles

Full Title Authors
Full Title Authors
65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine Ji Won Kim · Dharmendra K. Yadav · Soo Jin Kim · Moo-Yeol Lee · Jung-Min Park · Bum Seok Kim · Mi-hyun Kim · Hyeung-geun Park · Keon Wook Kang · Keon Wook Kang
Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer Jonathan Wesley Nyce · Jonathan Wesley Nyce
Hyperglycemia decreases anti-cancer efficiency of Adriamycin via AMPK pathway Robert C. Mould · Jacob P. van Vloten · Amanda W. K. AuYeung · Khalil Karimi · Byram W. Bridle · Byram W. Bridle
Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells Joanna Grey · Kym Winter · Kym Winter
Attenuation of NK cells facilitates mammary tumor growth in streptozotocin-induced diabetes in mice Kwon Joong Na · Hongyoon Choi · Hongyoon Choi
Immune landscape of papillary thyroid cancer and immunotherapeutic implications Anela Blažević · Johannes Hofland · Leo J. Hofland · Richard A. Feelders · Wouter W. de Herder · Wouter W. de Herder
Small intestinal neuroendocrine tumours and fibrosis Seong-Jang Kim · Sang-Woo Lee · Kyoungjune Pak · Sung Ryul Shim · Sung Ryul Shim
Diagnostic performance of PET in thyroid cancer with elevated anti-Tg Ab Massimo Milione · Patrick Maisonneuve · Alessio Pellegrinelli · Federica Grillo · Luca Albarello · Paola Spaggiari · Alessandro Vanoli · Giovanna Tagliabue · Eleonora Pisa · Luca Messerini · Giovanni Centonze · Frediano Inzani · Aldo Scarpa · Mauro Papotti · Marco Volante · Fausto Sessa · Nicola Fazio · Giancarlo Pruneri · Guido Rindi · Enrico Solcia · Stefano La Rosa · Carlo Capella · Carlo Capella
Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis Hiroki Ueda · Yoshimitsu Akiyama · Shu Shimada · Kaoru Mogushi · Misaki Serizawa · Satoshi Matsumura · Yusuke Mitsunori · Arihiro Aihara · Daisuke Ban · Takanori Ochiai · Atsushi Kudo · Minoru Tanabe · Shinji Tanaka · Shinji Tanaka
Sulforaphane metabolites cause apoptosis via microtubule disruption in cancer Antonio De la Vieja · Pilar Santisteban · Pilar Santisteban · Pilar Santisteban
Novel targeted therapeutics for MEN2 Tobias Hofving · Yvonne Arvidsson · Bilal Almobarak · Linda Inge · Roswitha Pfragner · Marta Persson · Göran Stenman · Erik Kristiansson · Viktor Johanson · Ola Nilsson · Ola Nilsson
65 YEARS OF THE DOUBLE HELIX: Could Watson and Crick have envisioned the true impact of their discovery? Zi Ying Tan · Taosheng Huang · Joanne Ngeow · Joanne Ngeow
TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer Xianhui Ruan · Xianle Shi · Qiman Dong · Yang Yu · Xiukun Hou · Xinhao Song · Xi Wei · Lingyi Chen · Ming Gao · Ming Gao
Modifying impact of RET gene haplotypes on medullary thyroid carcinoma clinical course Andreas Machens · Kerstin Lorenz · Frank Weber · Henning Dralle · Henning Dralle
Treatment of pituitary tumors with temozolomide: an update Ilene Sussman · Ilene Sussman
Its all in the DNA: Understanding and managing endocrine neoplasms Mona Alharbi · Felipe A. Zuñiga · Omar Elfeky · Dominic Guanzon · Andrew Lai · Gregory E. Rice · Lewis Perrin · John D. Hooper · Carlos Salomon · Carlos Salomon
Penetrance of phaeochromocytoma in RET G533C carriers differs between South America and Europe M Principe · M Chanal · V Karam · A Wierinckx · I Mikaélian · R Gadet · C Auger · V Raverot · E Jouanneau · A Vasiljevic · A Hennino · Gérald Raverot · P Bertolino · P Bertolino
IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancer Marianne Pavel · David J. Gross · Marta Benavent · Petros Perros · Raj Srirajaskanthan · Richard R.P. Warner · Matthew H. Kulke · Lowell B. Anthony · Pamela L. Kunz · Dieter Hörsch · Martin O. Weickert · Pablo Lapuerta · Wenjun Jiang · Kenneth Kassler-Taub · Suman Wason · Rosanna Fleming · Douglas Fleming · R. Garcia-Carbonero · R. Garcia-Carbonero
FAM129A regulates autophagy in thyroid carcinomas in an oncogene-dependent manner Martin Ullrich · Josephine Liers · Mirko Peitzsch · Anja Feldmann · Ralf Bergmann · Ulrich Sommer · Susan Richter · Stefan R. Bornstein · Michael H. Bachmann · Graeme Eisenhofer · Christian G. Ziegler · Jens Pietzsch · Jens Pietzsch
Strain-specific metastatic phenotypes in pheochromocytoma allograft mice Jonathan Wesley Nyce · Jonathan Wesley Nyce
Species-specific mechanisms of tumor suppression: trouble in paradigm Lois M. Mulligan · Lois M. Mulligan
DICER1 gene mutations in endocrine tumors Stefan Z. Lutz · Tilman Todenhöfer · Robert Wagner · Jörg Hennenlotter · Jana Marlene Ferchl · Marcus Scharpf · Peter Martus · Harald Staiger · Andreas Fritsche · A. Stenzl · Hans-Ulrich Häring · Martin Heni · Martin Heni
65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma William D. Foulkes · Jérôme Bertherat · Charis Eng · Charis Eng
Towards optimal personalized diet and vitamin supplementation in NET patients Sara Redaelli · Ivan Plaza-Menacho · Luca Mologni · Luca Mologni
Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer William D. Foulkes · Jérôme Bertherat · Charis Eng · Charis Eng
Role of the tumor microenvironment in digestive neuroendocrine tumors Wei Guan · Junhui Hu · Lu Yang · Ping Tan · Zhuang Tang · Brian L. West · Gideon Bollag · Hua Xu · Lily Wu · Lily Wu
Sex steroids in the tumor microenvironment and prostate cancer progression Haleh Vosgha · Armin Ariana · Robert A. Smith · Robert A. Smith · Alfred King-Yin Lam · Alfred King-Yin Lam
Antitumor effects of anlotinib in thyroid cancer Thomas Cuny · Wouter W. de Herder · Anne Barlier · Leo J. Hofland · Leo J. Hofland
GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling Nelson Rangel · Milena Rondón-Lagos · Laura Annaratone · Simona Osella-Abate · Jasna Metovic · Maria Piera Mano · Luca Bertero · Paola Cassoni · Anna Sapino · Isabella Castellano · Isabella Castellano
The impact of 27-hydroxycholesterol on endometrial cancer proliferation Mark A. White · Efrosini Tsouko · Chenchu Lin · Kimal Rajapakshe · Jeffrey M Spencer · Sandi R Wilkenfeld · Sheiva S Vakili · Thomas L Pulliam · Dominik Awad · Fotis Nikolos · Rajasekhara Reddy Katreddy · Benny Abraham Kaipparettu · Arun Sreekumar · Xiaoliu Zhang · Edwin Cheung · Cristian Coarfa · Daniel E. Frigo · Daniel E. Frigo
HSD17B1 expression induces inflammation-aided rupture of mammary gland myoepithelium Douglas A. Gibson · Frances Collins · Fiona L. Cousins · Arantza Esnal Zufiaurre · Philippa T. K. Saunders · Philippa T. K. Saunders
Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer Mieke Henfling · Aurel Perren · Anja Schmitt · Christiane Saddig · Achim Starke · Robert G Riedl · Yvonne M.H. Versleijen-Jonkers · Diana Sprij-Mooij · Frans C. S. Ramaekers · Leo J. Hofland · Ernst-Jan M. Speel · Ernst-Jan M. Speel
Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors A. Berdelou · Livia Lamartina · Michele Klain · Sophie Leboulleux · Martin Schlumberger · Martin Schlumberger
KLF14 potentiates oxidative adaptation via modulating HO-1 signaling in castrate-resistant prostate cancer Simon Linder · Henk G. van der Poel · Andries M. Bergman · Wilbert Zwart · Stefan Prekovic · Stefan Prekovic
The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2 Päivi Järvensivu · Taija Heinosalo · Janne Hakkarainen · Pauliina Kronqvist · Niina Saarinen · Matti Poutanen · Matti Poutanen
PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients Serisha Moodley · Frank Weber · Lois M. Mulligan · Lois M. Mulligan
TERT structural rearrangements in metastatic pheochromocytomas Justin C. Brown · Michael R. Rickels · Andrea B. Troxel · Babette S. Zemel · Nevena Damjanov · Bonnie Ky · Andrew D. Rhim · Anil K. Rustgi · Kerry S. Courneya · Kathryn H. Schmitz · Kathryn H. Schmitz
Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Trisha Dwight · Aidan Flynn · Kaushalya C. Amarasinghe · Diana E. Benn · Richard Lupat · Jason Li · Daniel Cameron · Annette Hogg · Shiva Balachander · Ida Candiloro · Stephen Q. Wong · Bruce G. Robinson · Anthony T. Papenfuss · Anthony J. Gill · Alexander Dobrovic · Rodney J. Hicks · Roderick J. Clifton-Bligh · Richard W. Tothill · Richard W. Tothill
The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative Gianmarco Leone · Marcello Tucci · Consuelo Buttigliero · Clizia Zichi · Daniele Pignataro · Paolo Bironzo · Francesca Vignani · Giorgio V. Scagliotti · Massimo Di Maio · Massimo Di Maio
65 YEARS OF THE DOUBLE HELIX: Classification of endocrine tumors in the age of integrated genomics Carole Guerin · Pauline Romanet · David Taïeb · Thierry Brue · André Lacroix · Frederic Sebag · Anne Barlier · F. Castinetti · F. Castinetti
Detection of a novel, primate-specific kill switch tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53 Xiaqing Xu · Meimei Si · Honggang Lou · Youyou Yan · Yunxi Liu · Hong Zhu · Xiaoe Lou · Jian Ma · Difeng Zhu · Honghai Wu · Bo Yang · Haoshu Wu · Ling Ding · Qiaojun He · Qiaojun He
Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer Gido Snaterse · Jenny A. Visser · Wiebke Arlt · Johannes Hofland · Johannes Hofland
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Zhu Wang · Dinglan Wu · Dinglan Wu · Chi-Fai Ng · Jeremy Yuen-Chun Teoh · Shan Yu · Yuliang Wang · Franky L. Chan · Franky L. Chan
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance Shu-Fu Lin · Jen-Der Lin · Chuen Hsueh · Ting-Chao Chou · Richard J. Wong · Richard J. Wong
Proteomics study of serum exosomes from papillary thyroid cancer patients Elke Tatjana Aristizabal Prada · Gerald Spöttl · Julian Maurer · Michael Lauseker · Eva Jolanthe Koziolek · Jörg Schrader · Ashley B. Grossman · Karel Pacak · Felix Beuschlein · Christoph Auernhammer · Svenja Nölting · Svenja Nölting
The hypothalamic pituitary adrenal axis in childhood cancer survivors Dan Luo · Shaohua Zhan · Wenchao Xia · Liang Huang · Wei Ge · Tianxiao Wang · Tianxiao Wang
Splicing dysregulation as a driver of breast cancer Christina Wei · Elizabeth Crowne · Elizabeth Crowne
GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer Lois M. Mulligan · Lois M. Mulligan
Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer Abigail Read · Rachael Natrajan · Rachael Natrajan
Dose–response effects of exercise on insulin among colon cancer survivors Priscilla Cukier · Fernando Costa Santini · Mariana Scaranti · Ana O. Hoff · Ana O. Hoff
Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer Biao Wan · Leheyi Dai · Li Wang · Ying Zhang · Hong Huang · Guanhua Qian · Tinghe Yu · Tinghe Yu
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients Michael Solarski · Fabio Rotondo · William D. Foulkes · William D. Foulkes · John R. Priest · Luis V. Syro · Henriett Butz · Michael D. Cusimano · Kalman Kovacs · Kalman Kovacs
Classification of gastrointestinal stromal tumor syndromes Avaniyapuram Kannan Murugan · Arasambattu Kannan Munirajan · Ali S. Alzahrani · Ali S. Alzahrani
Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivo Anela Blažević · Wouter T Zandee · Gaston J H Franssen · J. Hofland · Marie-Louise F van Velthuysen · L. J. Hofland · R. A. Feelders · Wouter W. de Herder · Wouter W. de Herder
Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation Yilun Deng · Shahida K. Flores · Zi Ming Cheng · Yuejuan Qin · Robin C. Schwartz · Carl D. Malchoff · Patricia L M Dahia · Patricia L M Dahia
Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredicts value Anela Blažević · J. Hofland · L. J. Hofland · R. A. Feelders · Wouter W. de Herder · Wouter W. de Herder
Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells Jingqi Fu · Hongzhi Zheng · Qi Cui · Chengjie Chen · Simeng Bao · Jing Sun · Lu Li · Bei Yang · Huihui Wang · Yongyong Hou · Yuanyuan Xu · Yuanhong Xu · Qiang Zhang · Jingbo Pi · Jingbo Pi
Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: a novel model of invasive medullary thyroid carcinoma Hongqiang Wang · Rui Zhou · Li Sun · Jianling Xia · Xuchun Yang · Changqie Pan · Na Huang · Min Shi · Jianping Bin · Yulin Liao · Wangjun Liao · Wangjun Liao
Long noncoding RNAs: emerging players in thyroid cancer pathogenesis Sara Molatore · Andrea Kügler · Martin Irmler · Tobias Wiedemann · Frauke Neff · Annette Feuchtinger · Johannes Beckers · Mercedes Robledo · Federico Roncaroli · Natalia S. Pellegata · Natalia S. Pellegata
TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Priya Gopie · Lin Mei · Anthony C. Faber · Steven R. Grossman · Steven C. Smith · Sosipatros A. Boikos · Sosipatros A. Boikos
Ex vivo activity of cytotoxic drugs and targeted agents in small intestinal neuroendocrine tumors Samuel A. Wells · Samuel A. Wells
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers Kosmas Daskalakis · Olov Norlén · Andreas Karakatsanis · Per Hellman · Rolf Larsson · Peter Nygren · Peter Stålberg · Peter Stålberg
The next step: mechanisms driving adrenocortical carcinoma metastasis Philipp Y. Maximov · Balkees Abderrahman · Ramona Curpan · Yousef M. Hawsawi · Ping Fan · V. Craig Jordan · V. Craig Jordan
A novel model to predict positive prostate biopsy based on serum androgen level Enzo Lalli · Michaela Luconi · Michaela Luconi
Differentiated thyroid cancer: millions spent with no tangible gain? Takeshi Ujike · Motohide Uemura · Atsunari Kawashima · Akira Nagahara · Kazutoshi Fujita · Yasushi Miyagawa · Norio Nonomura · Norio Nonomura
ROS-induced near-homozygous genomes in thyroid cancer Luis Furuya-Kanamori · Art Sedrakyan · Adedayo A. Onitilo · Nasser Bagheri · Paul Glasziou · Suhail A. R. Doi · Suhail A. R. Doi
Advances in adrenal tumors 2018 Matias Knuuttila · Arfa Mehmood · Jenni Mäki-Jouppila · Henrik Ryberg · Pekka Taimen · Juha Knaapila · Otto Ettala · Peter J. Boström · Claes Ohlsson · Mikko S. Venäläinen · Asta Laiho · Laura L. Elo · Petra Sipilä · Sari Mäkelä · Matti Poutanen · Matti Poutanen
One gene - many endocrine and metabolic syndromes: PTEN-opathies and precision medicine Joakim Crona · Felix Beuschlein · Karel Pacak · Britt Skogseid · Britt Skogseid
Genetics Informs Precision Practice in the Diagnosis and Management of Pheochromocytoma Lamis Yehia · Charis Eng · Charis Eng
Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer Yong-Zi Chen · Youngchul Kim · Hatem H Soliman · GuoGuang Ying · Jae K. Lee · Jae K. Lee
Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs Stefano Mangiola · Ryan Stuchbery · Geoff Macintyre · Michael J. Clarkson · Justin Peters · Anthony J. Costello · Christopher M. Hovens · Niall M. Corcoran · Niall M. Corcoran
Single drug biomarker prediction for ER− breast cancer outcome from chemotherapy Huy Gia Vuong · Toru Odate · Hanh T.T. Ngo · Thong Quang Pham · Thao T.k. Tran · Kunio Mochizuki · Tadao Nakazawa · Ryohei Katoh · Tetsuo Kondo · Tetsuo Kondo
Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms Hartmut P. H. Neumann · William F. Young · Tobias Krauss · Jean-Pierre Bayley · Francesca Schiavi · Giuseppe Opocher · Carsten Christof Boedeker · Amit Tirosh · Frederic Castinetti · Juri Ruf · Dmitry Beltsevich · Martin K. Walz · Harald Groeben · Ernst von Dobschuetz · Oliver Gimm · Nelson Wohllk · Marija Pfeifer · Delmar M. Lourenço · Mariola Pęczkowska · Attila Patócs · Joanne Ngeow · Özer Makay · Nalini S. Shah · Arthur S. Tischler · Helena Leijon · Gianmaria Pennelli · Karina Villar Gómez de las Heras · Thera P. Links · Birke Bausch · Charis Eng · Charis Eng
Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis Bianca Cioni · Wilbert Zwart · Andries M. Bergman · Andries M. Bergman
Androgen receptor moonlighting in the prostate cancer microenvironment Maria Domenica Castellone · Rosa Marina Melillo · Rosa Marina Melillo
Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicity Chen Wang · Xin Zhang · Xue Yang · Hui Li · Ruixue Cui · Wenmin Guan · Xin Li · Zhaohui Zhu · Yansong Lin · Yansong Lin
PET response assessment in apatinib treated radioactive iodine-refractory thyroid cancer Shani Avniel-Polak · Gil Leibowitz · Victoria Doviner · David J. Gross · Simona Grozinsky-Glasberg · Simona Grozinsky-Glasberg
Combining chloroquine with RAD001 inhibits tumor growth in a NEN mouse model Giovanni Vitale · Alessandra Dicitore · Concetta Sciammarella · Sergio Di Molfetta · Manila Rubino · Antongiulio Faggiano · Annamaria Colao · Annamaria Colao
Pasireotide in the treatment of neuroendocrine tumors: a review of the literature Ken Chow · Stefano Mangiola · Jaideep Vazirani · Justin Peters · Anthony J. Costello · Christopher M. Hovens · Niall M. Corcoran · Niall M. Corcoran
Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells Nevena Gajovic · Milena Jurisevic · Jelena Pantic · Gordana Radosavljevic · Nebojsa Arsenijevic · Miodrag L. Lukic · Ivan Jovanović · Ivan Jovanović
Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors Yu Tang Chin · Po Li Wei · Yih Ho · André Wendindondé Nana · Chun A. Changou · Yi Ru Chen · Yu Chen Sh Yang · Meng Ti Hsieh · Aleck Hercbergs · Paul J. Davis · Ya Jung Shih · Hung Yun Lin · Hung Yun Lin
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors Elke Tatjana Aristizabal Prada · Vera Heinzle · Thomas Knösel · Svenja Nölting · Gerald Spoettl · Julian Maurer · Christine Spitzweg · Martin K. Angele · Nina Schmidt · Felix Beuschlein · Günter K. Stalla · Rainer Blaser · Klaus A. Kuhn · Christoph J. Auernhammer · Christoph J. Auernhammer
Exploiting insights on the RET receptor for personalized cancer medicine Chiara Verdelli · Irene Forno · Annamaria Morotti · Pasquale Creo · Vito Guarnieri · Alfredo Scillitani · Filomena Cetani · Leonardo Vicentini · Gianni Balza · Edoardo Beretta · Stefano Ferrero · Valentina Vaira · Sabrina Corbetta · Sabrina Corbetta
The aberrantly expressed miR-372 partly impairs sensitivity to apoptosis in parathyroid tumor cells Amruta Ashtekar · Danielle Huk · Alexa Magner · Krista La Perle · Xiaoli Zhang · José I. Piruat · José López-Barneo · Sissy M. Jhiang · Lawrence S. Kirschner · Lawrence S. Kirschner
TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours Erin E. Swinstead · Ville Paakinaho · Gordon L. Hager · Gordon L. Hager
Chromatin reprogramming in breast cancer Vanida Ann Serna · Xin Wu · Wenan Qiang · Justin Thomas · Michael L Blumenfeld · Takeshi Kurita · Takeshi Kurita
Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo Thomas Ho Lai Yau · Kwok-Leung Cheung · Kwok-Leung Cheung
Optimising endocrine therapy in postmenopausal women with advanced breast cancer Claudia Tulotta · Penelope D. Ottewell · Penelope D. Ottewell
The role of IL-1B in breast cancer bone metastasis Bin Zhao · Hong Zhao · Jiaxin Zhao · Jiaxin Zhao
Impact of hormone receptor status on the efficacy of HER2-targeted treatment Maria Chiara Zatelli · Elia Guadagno · Erika Messina · Fabio Lo Calzo · Antongiulio Faggiano · Annamaria Colao · Annamaria Colao
Open issues on G3 neuroendocrine neoplasms: back to the future Ian S Fentiman · Ian S Fentiman
The endocrinology of male breast cancer Andrew G Gianoukakis · Corina E. Dutcus · Nicolas Batty · Matthew Guo · Mahadi Ali Baig · Mahadi Ali Baig
Prolonged duration of response in lenvatinib responders with thyroid cancer Ninu Poulose · Ian G. Mills · Rebecca E. Steele · Rebecca E. Steele
The impact of transcription on metabolism in prostate and breast cancers Tom Lees · Angharad Cullinane · Alexandra Condon · Abeer M Shabaan · Matthew P. Humphries · Valerie Speirs · Valerie Speirs
Characterising the adipose-inflammatory microenvironment in male breast cancer Tobias Krauss · Alfonso Massimiliano Ferrara · Thera P. Links · Ulrich F. Wellner · Irina Bancos · Andrey Kvachenyuk · Karina Villar Gómez de las Heras · Marina Yukina · Roman Petrov · Garrett Bullivant · Laura von Duecker · Swati S Jadhav · Ursula Ploeckinger · Staffan Welin · Camilla Schalin-Jäntti · Oliver Gimm · Marija Pfeifer · Joanne Ngeow · Kornelia Hasse-Lazar · Gabriela Sanso · Xiao-Ping Qi · Umit Ugurlu · Rene Eduardo Diaz · Nelson Wohllk · Mariola Pęczkowska · Jens Aberle · Delmar Munir Lourenço · Maria Adelaide Albergaria Pereira · Maria Candida Barisson Villares Fragoso · Ana O. Hoff · Madson Q. Almeida · Alice Helena Dutra Violante · Ana Rosa Pinto Quidute · Zheiwei Zhang · Monica Recasens · Luis Robles Diaz · Tada Kunavisarut · Taweesak Wannachalee · Sirinart Sirinvaravong · Eric Jonasch · Simona Grozinsky-Glasberg · Merav Fraenkel · Dmitry Beltsevich · Viacheslav I. Egorov · Dirk Bausch · Matthias Schott · Nikolaus Tiling · Gianmaria Pennelli · Stefan Zschiedrich · Roland Därr · Juri Ruf · Timm Denecke · Karl-Heinrich Link · Stefania Zovato · Svetlana Yaremchuk · Holger Amthauer · Özer Makay · Attila Patócs · Martin K. Walz · Tobias B. Huber · Jochen Seufert · Per Hellman · Raymond H. Kim · Ekaterina Kuchinskaya · Francesca Schiavi · Angelica Malinoc · Nicole Reisch · Barbara Jarzab · Marta Barontini · Andrzej Januszewicz · Nalini S. Shah · William F. Young · Giuseppe Opocher · Charis Eng · Hartmut P. H. Neumann · Birke Bausch · Birke Bausch
Preventive medicine for von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors Federica Grillo · Tullio Florio · Francesco Ferraù · Elda Kara · Giuseppe Fanciulli · Antongiulio Faggiano · Annamaria Colao · Annamaria Colao
Anaplastic thyroid carcinoma: review of treatment protocols Maria Teresa Valenti · Monica Mottes · Samuele Cheri · Michela Deiana · Valentina Micheletti · Elisa Cosaro · Maria Vittoria Davì · Giuseppe Francia · Luca Dalle Carbonare · Luca Dalle Carbonare
Obesity suppresses tumor attributable PSA, affecting risk categorization Corinne N Haines · Kara M. Braunreiter · Xiaokui M Mo · Craig J. Burd · Craig J. Burd
Runx2 overexpression compromises bone quality in acromegalic patients Thomas A. Werner · Inga Nolten · Levent Dizdar · Jasmin C. Riemer · Sina Christin Schütte · Pablo E. Verde · Katharina Raba · Matthias Schott · Wolfram T. Knoefel · Andreas Krieg · Andreas Krieg
65 YEARS OF THE DOUBLE HELIX: Endocrine tumour syndromes in children and adolescents Dorota Dworakowska · Ashley B. Grossman · Ashley B. Grossman
Frequency and consequence of the recurrent YY1 p.T372R mutation in sporadic insulinomas Isabel Amendoeira · Tiago Maia · Manuel Sobrinho-Simões · Manuel Sobrinho-Simões
An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target Christina Schug · Sarah Urnauer · Carsten Jäckel · Kathrin A. Schmohl · Mariella Tutter · Katja Steiger · Nathalie Schwenk · Markus Schwaiger · Ernst Wagner · Peter J. Nelson · Christine Spitzweg · Christine Spitzweg
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop Paraskevi Xekouki · Emily J. Lodge · Jakob Matschke · Alice Santambrogio · John R. Apps · Ariane Sharif · Ts Jacques · Simon Aylwin · Vincent Prevot · Ran Li · Jörg Flitsch · Stefan R. Bornstein · Marily Theodoropoulou · Cynthia L. Andoniadou · Cynthia L. Andoniadou
Attenuation of NK cells facilitates mammary tumor growth in STZ-induced diabetes in mice Belinda van Zyl · Denise Tang · Nikola A. Bowden · Nikola A. Bowden
Role of iodide metabolism in physiology and cancer Vaishali I. Parekh · Sita D Modali · James Welch · William F. Simonds · Lee S. Weinstein · Electron Kebebew · Sunita K. Agarwal · Sunita K. Agarwal
Geographic epidemiology of medullary thyroid cancer families: unearthing European ancestral heritage Nevena Gajovic · Milena Jurisevic · Jelena Pantic · Gordana Radosavljevic · Nebojsa Arsenijevic · Miodrag L. Lukic · Ivan Jovanovic · Ivan Jovanovic
Non-mammalian models of multiple endocrine neoplasia type 2 Yan Zhou · Gaoxiang Yang · Hua Tian · Yabin Hu · Sai Wu · Yang Geng · Kai Lin · Wei Wu · Wei Wu
Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers Tirtha K. Das · Ross L. Cagan · Ross L. Cagan
Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment Joseph M Shulan · Leonid Vydro · Arthur B. Schneider · Dan Mihailescu · Dan Mihailescu
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): impact on the reclassification of thyroid nodules Minlu Zhang · Peng Peng · Kai Gu · Hui Cai · Guoyou Qin · Xiao-Ou Shu · Ping-Ping Bao · Ping-Ping Bao
Role of biomarkers in predicting the occurrence of thyroid neoplasms in radiation-exposed children James Koh · Joyce A. Hogue · Sanziana A. Roman · Randall P. Scheri · Hèléne Fradin · David L. Corcoran · Julie Ann Sosa · Julie Ann Sosa
Time-varying effects of prognostic factors associated with long-term survival in breast cancer Berna Ozdemir · Georgios Sflomos · Cathrin Brisken · Cathrin Brisken
65 YEARS OF THE DOUBLE HELIX: Treatment of pituitary tumors with temozolomide: an update Lamis Yehia · Charis Eng · Charis Eng
Aggressive and malignant pituitary tumours: state-of-the-art Caroline A. Lamb · Victoria Fabris · Britta M. Jacobsen · Alfredo A. Molinolo · Claudia Lanari · Claudia Lanari
Molecular underpinnings of enzalutamide resistance Luis V. Syro · Fabio Rotondo · Leon D. Ortiz · Kalman Kovacs · Kalman Kovacs
65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine Rui M. B. Maciel · Larissa V. Bim · Cléber P. Camacho · Janete M. Cerutti · Janete M. Cerutti
Tumor cells may circulate in medullary thyroid cancer patients independently of serum calcitonin Veronica Vella · Maria Luisa Nicolosi · Patrizia Cantafio · Michele Massimino · Rosamaria Lappano · Paolo Vigneri · Roberto Ciuni · Pietro Gangemi · Andrea Morrione · Roberta Malaguarnera · Antonino Belfiore · Antonino Belfiore
Transcriptional profiling reveals distinct classes of parathyroid tumors in PHPT Tiago Vieira Augusto · Georgina Correia-da-Silva · Cecília M. P. Rodrigues · Natércia Teixeira · Cristina Amaral · Cristina Amaral
Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas Stefan Prekovic · Thomas Van den Broeck · Simon Linder · Martin E. van Royen · Adriaan B. Houtsmuller · Florian Handle · Steven Joniau · Wilbert Zwart · Frank Claessens · Frank Claessens
ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation A Coopes · C E Henry · E Llamosas · C E Ford · C E Ford
The challenges of modeling hormone receptor-positive breast cancer in mice Luis V. Syro · Fabio Rotondo · Leon D. Ortiz · Kalman Kovacs · Kalman Kovacs
Acquired-resistance to aromatase inhibitors: where we stand! Adrian Daly · Emilie Castermans · Lindsey Oudijk · Mirtha Guitelman · Pablo Beckers · Iulia Potorac · Sebastian Neggers · Nathalie Sacre · Aart-Jan van der Lely · Vincent Bours · Wouter W. de Herder · Albert Beckers · Albert Beckers
The IGF pathway is activated in insulinomas but downregulated in metastatic disease Sathya Neelature Sriramareddy · Etienne Hamoir · Marcela Chavez · Renaud Louis · Albert Beckers · Luc Willems · Luc Willems
65 YEARS OF THE DOUBLE HELIX: The advancements of gene editing and potential application to hereditary cancer Catherine Goudie · Fady Hannah-Shmouni · Mahmure Kavak · Constantine A. Stratakis · William D. Foulkes · William D. Foulkes
Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions Na Li · Huanni Li · Lanqing Cao · Xianquan Zhan · Xianquan Zhan
Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ Xiao-hui Luo · Jian-zhou Liu · Bo Wang · Qun-li Men · Yu-quan Ju · Feng-yan Yin · Chao Zheng · Wei Li · Wei Li
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines Marta Kaczmarek-Ryś · Katarzyna Ziemnicka · Andrzej Pławski · Bartlomiej Budny · Michał Michalak · Szymon Hryhorowicz · Justyna Hoppe-Gołębiewska · Pawel Borun · Monika Gołąb · Małgorzata Czetwertyńska · Maria Sromek · Marlena Szalata · Marek Ruchała · Ryszard Słomski · Ryszard Słomski
The role of the AR/ER ratio in ER-positive breast cancer patients Carolyn M. Klinge · Carolyn M. Klinge
The potential role of miRNAs and exosomes in chemotherapy in ovarian cancer Emma Rewcastle · Anne Elin Varhaugvik · Einar Gudlaugsson · Anita Steinbakk · Ivar Skaland · Bianca van Diermen · Jan P. A. Baak · Emiel A.M. Janssen · Emiel A.M. Janssen
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial Daniely Regina Freitas-Alves · Hayra de Andrade Vieira-Monteiro · Diogo Nascimento Piranda · Marcelo Sobral-Leite · Taiana Sousa Lopes da Silva · Anke Bergmann · Samuel dos Santos Valença · Jamila Alessandra Perini · Rosane Vianna-Jorge · Rosane Vianna-Jorge
Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes Clovis Boibessot · Paul Toren · Paul Toren
Overcoming CDK4/6 inhibitor resistance in ER positive breast cancer Joanne Ngeow · Laura Sterian Ward · Laura Sterian Ward
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond Neil Portman · Sarah Alexandrou · Emma Carson · Shudong Wang · Elgene Lim · Catherine Elizabeth Caldon · Catherine Elizabeth Caldon
Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis Martin K. Bakht · Iulian Derecichei · Yinan Li · Rosa-Maria Ferraiuolo · Mark J. Dunning · So Won Oh · Abdulkadir Hussein · Hyewon Youn · Keith F Stringer · Chang Wook Jeong · Gi Jeong Cheon · Cheol Kwak · Keon Wook Kang · Alastair D. Lamb · Yuzhuo Wang · Xuesen Dong · Lisa A. Porter · Lisa A. Porter
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression Hartmut P. H. Neumann · William F. Young · Tobias Krauss · Jean-Pierre Bayley · Francesca Schiavi · Giuseppe Opocher · Carsten Christof Boedeker · Amit Tirosh · Frederic Castinetti · Juri Ruf · Dmitry Beltsevich · Martin K. Walz · Harald-Thomas Groeben · Ernst von Dobschuetz · Oliver Gimm · Nelson Wohllk · Marija Pfeifer · Delmar M. Lourenço · Mariola Pęczkowska · Attila Patócs · Joanne Ngeow · Özer Makay · Nalini S. Shah · Arthur S. Tischler · Helena Leijon · Gianmaria Pennelli · Karina Villar Gómez de las Heras · Thera P. Links · Birke Bausch · Charis Eng · Charis Eng
Development of new preclinical models to advance adrenocortical carcinoma research L.D. de Hosson · J Stelwagen · G. Bouma · B Sijtema · S Huitema · H. van Faassen · G. H. de Bock · D. J. A. de Groot · M J E Campmans-Kuijpers · Ido P. Kema · E.G.E. de Vries · Annemiek M.E. Walenkamp · Annemiek M.E. Walenkamp
Treatment of refractory thyroid cancer Katja Kiseljak-Vassiliades · Yu Zhang · Stacey Bagby · Adwitiya Kar · Nikita Pozdeyev · Mei Xu · Katherine Gowan · Vibha Sharma · Christopher D. Raeburn · Maria Albuja-Cruz · Kenneth L. Jones · Lauren Fishbein · Rebecca E. Schweppe · Hilary Somerset · Todd M. Pitts · Stephen Leong · Margaret E. Wierman · Margaret E. Wierman
miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinoma Atsuko Kasajima · Yuichi Ishikawa · Ayaka Iwata · Katja Steiger · Naomi Oka · Hirotaka Ishida · Akira Sakurada · Hiroyoshi Suzuki · Toru Kameya · Björn Konukiewitz · Günter Klöppel · Yoshinori Okada · Hironobu Sasano · Wilko Weichert · Wilko Weichert
The clinical importance of quantifying body fat distribution during androgen deprivation therapy for prostate cancer Stephen John Foulkes · Robin M. Daly · Steve F. Fraser · Steve F. Fraser
A review of estrogen receptor/androgen receptor genomics in male breast cancer Tesa Severson · Wilbert Zwart · Wilbert Zwart
Comprehensive screening for PD-L1 expression in thyroid cancer Soomin Ahn · Tae Hyuk Kim · Sun Wook Kim · Hye Won Jang · Jee Soo Kim · J.H. Kim · Jun-Ho Choe · Jung Hee Shin · Soo Yeon Hahn · Young Lyun Oh · Jae Hoon Chung · Jae Hoon Chung
Copy number variations of E2F1: A new genetic risk factor for testicular cancer Maria Santa Rocca · Andrea Di Nisio · Arianna Marchiori · Marco Ghezzi · Giuseppe Opocher · Carlo Foresta · Alberto Ferlin · Alberto Ferlin
Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer Shuk-Mei Ho · Rahul C Rao · Sarah To · Emma Schoch · Pheruza Tarapore · Pheruza Tarapore
Paleogenetic study of ancient DNA suggestive of X-Linked acrogigantism Albert Beckers · Daniel Fernandes · F. Fina · Mario Novak · Angelo Abati · Liliya Rostomyan · Albert Thiry · L’Housine Ouafik · Bertrand Pasture · Ron Pinhasi · Adrian Daly · Adrian Daly
Thyroid nodules and cancer management guidelines: comparisons and controversies Fadi Nabhan · Matthew D. Ringel · Matthew D. Ringel
Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines Margaux Foulfoin · Emmanuelle Graillot · Mustapha Adham · Pascal Rousset · Julien Forestier · Valérie Hervieu · Philip Robinson · Jean-Yves Scoazec · Catherine Lombard-Bohas · Thomas Walter · Thomas Walter
Regression of advanced neuroendocrine tumors among patients receiving placebo Vito Amoroso · Giorgio Maria Agazzi · Elisa Roca · Nicola Fazio · Alessandra Mosca · Marco Ravanelli · Francesca Spada · Roberto Maroldi · Alfredo Berruti · Alfredo Berruti
Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma Thibault Bahougne · Alessio Imperiale · Gerlinde Averous · Gérard Chabrier · Nelly Burnichon · Anne Paule Gimenez-Roqueplo · Nassim Dali-Youcef · Rossella Libe · Eric Baudin · Catherine Roy · H. Lang · L. Kessler · L. Kessler
Differential roles of RET isoforms in medullary and papillary thyroid carcinomas Eric Lian · Sarah M. Maritan · Jessica G. Cockburn · Katayoon Kasaian · Mathieu J. F. Crupi · David Hurlbut · Steven J.M. Jones · Sam M. Wiseman · Lois M. Mulligan · Lois M. Mulligan
Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1 Koen Dreijerink · H.T. Marc Timmers · Myles Brown · Myles Brown
Germline mutation contribution to chromosomal instability Sock Hoai Chan · Joanne Ngeow · Joanne Ngeow
Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy Giorgio Secreto · Paola Muti · Milena Sant · Elisabetta Meneghini · Vittorio Krogh · Vittorio Krogh
Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Keren Cohen · Uri Abadi · Aleck Hercbergs · Paul J. Davis · Martin Ellis · Osnat Ashur-Fabian · Osnat Ashur-Fabian
Glycosylation is a global target for androgen control in prostate cancer cells Jennifer Munkley · Jennifer Munkley
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2) Maria Wielsøe · Christian Bjerregaard-Olesen · Peder Kern · Eva Cecilie Bonefeld-Jørgensen · Eva Cecilie Bonefeld-Jørgensen
Genetic testing for indeterminate thyroid cytology: review and meta-analysis Vera Tiedje · Martin Stuschke · Frank Weber · Henning Dralle · Laura Moss · Dagmar Führer · Dagmar Führer
Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer Sergio Vargas-Salas · José R. Martínez · Soledad Urra · José Miguel Domínguez · Natalia Mena · Thomas Uslar · Marcela Lagos · Marcela Henríquez · Hernán E. González · Hernán E. González
Copy number profiling of oncogenes in ductal carcinoma in situ of the male breast Koji Tsumagari · Zakaria Y. Abd Elmageed · Andrew B. Sholl · Erik A Green · Saboori Sobti · Abdul Razzaq Khan · Abdulrahman Kandil · Fadi Murad · Paul Friedlander · A. Hamid Boulares · Emad Kandil · Emad Kandil
Genetics of tumors of the adrenal cortex Marijn A. Vermeulen · Shusma C Doebar · Carolien H.M. van Deurzen · Carolien H.M. van Deurzen · John W.M. Martens · John W.M. Martens · Paul J. van Diest · Cathy B. Moelans · Cathy B. Moelans
Advances in risk-oriented surgery for multiple endocrine neoplasia type 2 Iván Plaza-Menacho · Iván Plaza-Menacho
Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology Pablo Valderrabano · Laila Khazai · Marino E. Leon · Zachary J. Thompson · Zhenjun Ma · Christine H. Chung · Julie E. Hallanger-Johnson · Kristen J. Otto · Kara D Rogers · Barbara A. Centeno · Bryan McIver · Bryan McIver
Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma Luca Morandi · Alberto Righi · Francesca Maletta · Paola Rucci · Fabio Pagni · Marco Gallo · Sabrina Rossi · Leonardo Caporali · Anna Sapino · Ricardo V. Lloyd · Sofia Asioli · Sofia Asioli
Differences in miRNA expression profiles between wild-type and mutated NIFTPs Maria Denaro · Clara Ugolini · Anello Marcello Poma · Nicla Borrelli · Gabriele Materazzi · Paolo Piaggi · Massimo Chiarugi · Paolo Miccoli · Paolo Vitti · Fulvio Basolo · Fulvio Basolo
Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases Anna Karpathakis · Harpreet Dibra · Christodoulos P Pipinikas · Andrew Feber · Tiffany Morris · Joshua M. Francis · Dahmane Oukrif · Dalvinder Mandair · Marinos Pericleous · Mullan Mohmaduvesh · Stefano Serra · Olagunju Ogunbiyi · Marco Novelli · Tu Vinh Luong · Sylvia L. Asa · Matthew H. Kulke · Christos Toumpanakis · Tim Meyer · Martyn Caplin · Stephan Beck · Christina Thirlwell · Christina Thirlwell
Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells Kirk Jensen · Athanasios Bikas · Aneeta Patel · Yevgeniya Kushchayeva · John Costello · Dennis P. McDaniel · Kenneth D. Burman · Vasily Vasko · Vasily Vasko
OP449 inhibits breast cancer growth without adverse metabolic effects Gadi Shlomai · Zara Zelenko · Irini Markella Antoniou · Marilyn Stasinopoulos · Aviva Tobin-Hess · Michael P. Vitek · Derek LeRoith · Emily Jane Gallagher · Emily Jane Gallagher
Fighting tubulin-targeting anticancer drug toxicity and resistance Roberta Visconti · Domenico Grieco · Domenico Grieco
Hypo-methylation mediates chromosomal instability in pancreatic NET Ilaria Marinoni · A Wiederkeher · Tabea Wiedmer · S Pantasis · A Di Domenico · R Frank · Erik Vassella · Anja Schmitt · Aurel Perren · Aurel Perren
MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine Tahmineh Tabrizian · Donghai Wang · Fangxia Guan · Zunju Hu · Amanda P. Beck · Fabien Delahaye · Derek M. Huffman · Derek M. Huffman
Pituitary acromegaly: not one disease Sylvia L Asa · Walter Kucharczyk · Shereen Ezzat · Shereen Ezzat
Lipomatous tumours in adrenal gland: WHO updates and clinical implications Alfred King-Yin Lam · Alfred King-Yin Lam
RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2) Mariana Fuertes · Melanie Sapochnik · Lucas Tedesco · Sergio A. Senin · Alejandra Attorresi · Pablo Ajler · Guillermo Carrizo · Andrés Cervio · Gustavo Sevlever · Juan José Bonfiglio · Günter K. Stalla · Eduardo Arzt · Eduardo Arzt
Cancer immunotherapy: unique perspectives for endocrine-related cancers Bruno Heidi Nakano Nozima · Thais Biude Mendes · Gustavo J.S. Pereira · Rodrigo Pinheiro Araldi · Edna Sadayo Miazato Iwamura · Soraya S. Smaili · Gianna Carvalheira · Janete M. Cerutti · Janete M. Cerutti
50 years on … the discovery of tubulin continues to advance cancer treatment Sara Pusceddu · Francesco Barretta · Annalisa Trama · Laura Botta · Massimo Milione · Roberto Buzzoni · Filippo de Braud · Vincenzo Mazzaferro · Ugo Pastorino · Ettore Seregni · Luigi Mariani · Gemma Gatta · Maria Di Bartolomeo · Daniela Femia · Natalie Prinzi · Jorgelina Coppa · Francesco Panzuto · Lorenzo Antonuzzo · Emilio Bajetta · Maria Pia Brizzi · Davide Campana · Laura Catena · Harry Comber · Fiona Dwane · Nicola Fazio · Antongiulio Faggiano · Dario Giuffrida · Kris Henau · Toni Ibrahim · Riccardo Marconcini · Sara Massironi · Maja Primic Žakelj · Francesca Spada · Salvatore Tafuto · Elizabeth Van Eycken · Jan Maaten Van der Zwan · Tina Žagar · Luca Giacomelli · Rosalba Miceli · Rosalba Miceli
The future: surgical advances in MEN1 therapeutic approaches and management strategies Karen Crasta · Ritu Aneja · Ritu Aneja
Paraneoplastic endocrine syndromes Samira M. Sadowski · Guillaume Cadiot · Eric Dansin · Pierre Goudet · Frédéric Triponez · Frédéric Triponez
Targeting the TSH receptor in thyroid cancer Georgios K. Dimitriadis · Anna Angelousi · Martin O. Weickert · Harpal S. Randeva · Gregory Kaltsas · Gregory Kaltsas · Gregory Kaltsas · Ashley B. Grossman · Ashley B. Grossman
Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate Christopher W. Rowe · Jonathan Paul · Craig Gedye · Jorge M. Tolosa · Cino Bendinelli · Shaun McGrath · Roger Smith · Roger Smith
Targeting PP2A to overcome enzalutamide resistance in AR+ breast tumors Carmela Ricciardelli · Carmela Ricciardelli
Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype Iuri Martin Goemann · Mirian Romitti · Erika Laurini de Souza Meyer · Simone Magagnin Wajner · Ana Luiza Maia · Ana Luiza Maia
Apc inactivation, but not obesity, synergizes with Pten deficiency to drive intestinal stem cell-derived tumorigenesis Damien A. Leach · Suzanne M. Powell · Charlotte L. Bevan · Charlotte L. Bevan
A six-genotype genetic prognostic model for papillary thyroid cancer Xiaopei Shen · Rengyun Liu · Mingzhao Xing · Mingzhao Xing
Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer Bethany Smith · Priyanka Agarwal · Neil A. Bhowmick · Neil A. Bhowmick
Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells Alfred King-Yin Lam · Nassim Saremi · Nassim Saremi
Role of thyroid hormones in the neoplastic process: an overview Johan O. Paulsson · Ninni Mu · Ivan Shabo · Na Wang · Jan Zedenius · Catharina Larsson · C. Christofer Juhlin · C. Christofer Juhlin
Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2 Kalina Biernacka · Raj Persad · Amit Bahl · David Gillatt · Jeffrey M P Holly · Claire M Perks · Claire M Perks
Incidence of malignant tumours in patients with a non-functioning pituitary adenoma Daniel S Olsson · Casper Hammarstrand · Ing-Liss Bryngelsson · Anna G. Nilsson · Eva Ingeborg Elisabeth Andersson · Gudmundur Johannsson · Oskar Ragnarsson · Oskar Ragnarsson
Local optometrists are a major source of referrals to a pituitary tumour clinic Haval Surchi · Bahram Jafar-Mohammadi · Aparna Pal · Simon Cudlip · Ashley B. Grossman · Ashley B. Grossman
Timing of multikinase inhibitor initiation in differentiated thyroid cancer Marcia S. Brose · Johannes W. A. Smit · Chia-Chi Lin · Fabián Pitoia · Marc Mardoche Fellous · Yoriko DeSanctis · Martin Schlumberger · Masayuki Tori · Iwao Sugitani · Iwao Sugitani
Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic Jue Shi · Timothy J. Mitchison · Timothy J. Mitchison
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal Sylvia L. Asa · O Casar-Borota · Philippe Chanson · Etienne Delgrange · P Earls · S Ezzat · Ashley B. Grossman · H Ikeda · N Inoshita · Niki Karavitaki · Márta Korbonits · Edward R. Laws · Maria Beatriz Lopes · Nicholas F. Maartens · Ian E. McCutcheon · O Mete · H Nishioka · Gérald Raverot · Federico Roncaroli · Wolfgang Saeger · Luis V. Syro · A Vasiljevic · C Villa · A Wierinckx · Jacqueline Trouillas · Jacqueline Trouillas
Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer Zaid Al-Qurayshi · Mohamed Ahmed Shama · Mohamed Ahmed Shama · Gregory W. Randolph · Emad Kandil · Emad Kandil
The EORTC module for quality of life in patients with thyroid cancer: phase III Susanne Singer · Susan J. Jordan · Laura D. Locati · Monica Pinto · Iwona M. Tomaszewska · Cláudia Araújo · Eva Hammerlid · E. Vidhubala · Olga Husson · Naomi Kiyota · Christine Brannan · Dina Salem · Eva Gamper · Juan Ignacio Arraras · Georgios Ioannidis · Guy Andry · Johanna Inhestern · Vincent Grégoire · Lisa Licitra · Lisa Licitra
Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer Masaki Shiota · Akira Yokomizo · Ario Takeuchi · Eiji Kashiwagi · Takashi Dejima · Junichi Inokuchi · Katsunori Tatsugami · Takeshi Uchiumi · Masatoshi Eto · Masatoshi Eto
Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines Eleanor Louise Woodward · Andrea Biloglav · Naveen Ravi · Minjun Yang · Lars Ekblad · Johan Wennerberg · Kajsa Paulsson · Kajsa Paulsson
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy Andrew M. K. Law · Elgene Lim · Elgene Lim · Christopher J. Ormandy · Christopher J. Ormandy · David Gallego-Ortega · David Gallego-Ortega · David Gallego-Ortega
Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training Niamh L Mundell · Robin M. Daly · Helen Macpherson · Steve F. Fraser · Steve F. Fraser
Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles Jenny G. Parvani · Mark W. Jackson · Mark W. Jackson
Epigenetic regulation by the menin pathway Zijie Feng · Jian Ma · Xianxin Hua · Xianxin Hua
New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas Rodrigo A. Toledo · Rodrigo A. Toledo
MEN4 and CDKN1B mutations: the latest of the MEN syndromes Rami Alrezk · Fady Hannah-Shmouni · Constantine A. Stratakis · Constantine A. Stratakis
Gestational high-fat diet and bisphenol A exposure heightens mammary cancer risk Yuet-Kin Leung · Vinothini Govindarajah · Ana Cheong · Jennifer Veevers · Dan Song · Robin Gear · Xuegong Zhu · Jun Ying · Ady Kendler · Mario Medvedovic · Scott M. Belcher · Shuk-Mei Ho · Shuk-Mei Ho
Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Thomas J. Giordano · Thomas J. Giordano
Happy 20th anniversary MEN1 : from positional cloning to gene function restoration Lucas Leite Cunha · Marjory Alana Marcello · Vinicius Rocha-Santos · Laura Sterian Ward · Laura Sterian Ward
Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission Frank Weber · Lois M. Mulligan · Lois M. Mulligan
The future: genetics advances in MEN1 therapeutic approaches and management strategies Sunmi Park · Mark C. Willingham · Jun Qi · Sheue-yann Cheng · Sheue-yann Cheng
Circulating steroid hormone variations throughout different stages of prostate cancer Sunita K. Agarwal · Sunita K. Agarwal
Circulating tumor cells and mirnas as prognostic markers in neuroendocrine neoplasms Maria Chiara Zatelli · Erika Grossrubatscher · Elia Guadagno · Concetta Sciammarella · Antongiulio Faggiano · Annamaria Colao · Annamaria Colao
The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma Jing Nie · Guang-long Huang · Shengze Deng · Yun Bao · Yawei Liu · Zhan-Peng Feng · Chao-Hu Wang · Ming Chen · Songtao Qi · Jun Pan · Jun Pan
miR-16 is highly expressed in Pagets associated osteosarcoma Darrell Green · Irina Mohorianu · Iain McNamara · Tamas Dalmay · William D. Fraser · William D. Fraser
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer Elisa Roca · Alfredo Berruti · Silviu Sbiera · Ida Rapa · Ester Oneda · Paola Sperone · Cristina L. Ronchi · Laura Ferrari · Salvatore Grisanti · Antonina Germano · Barbara Zaggia · Giorgio V. Scagliotti · Martin Fassnacht · Marco Volante · Massimo Terzolo · Mauro Papotti · Mauro Papotti
Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma Theo S. Plantinga · Mirela Sanda Petrulea · Marije Oosting · Leo A. B. Joosten · Doina Piciu · Johannes W. A. Smit · Romana T. Netea-Maier · Carmen E. Georgescu · Carmen E. Georgescu
Molecular imaging in the investigation of hypoglycaemic syndromes and their management David A. Pattison · Rodney J. Hicks · Rodney J. Hicks
Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies Anna Angelousi · Georgios K. Dimitriadis · Georgios Zografos · Svenja Nölting · Gregory Kaltsas · Gregory Kaltsas · Gregory Kaltsas · Ashley B. Grossman · Ashley B. Grossman
Very low expression of PD-L1 in medullary thyroid carcinoma Massimo Bongiovanni · Caterina Rebecchini · Chiara Saglietti · Jean-Luc Bulliard · Laura Marino · Laurence de Leval · Gerasimos P. Sykiotis · Gerasimos P. Sykiotis
Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study Jes Sloth Mathiesen · Jens Peter Kroustrup · Peter Vestergaard · Mette Madsen · Kirstine Stochholm · Per Løgstrup Poulsen · Åse Krogh Rasmussen · Ulla Feldt-Rasmussen · Sten Schytte · Henrik Baymler Pedersen · Christoffer Holst Hahn · Jens Bentzen · Mette Gaustadnes · Torben F. Ørntoft · Thomas V O Hansen · Finn Cilius Nielsen · Kim Brixen · Anja Lisbeth Frederiksen · Christian Godballe · Christian Godballe
Obesity and menopause modify the epigenomic profile of breast cancer Ana B. Crujeiras · Angel Diaz-Lagares · Olafur A. Stefansson · Juan Sandoval · Juan Cueva · Rafael Lopez-Lopez · Sebastian Moran · Jon G. Jonasson · Laufey Tryggvadottir · Elinborg J Olafsdottir · Francisco J. Tinahones · Francisco J. Tinahones · Marcos C. Carreira · Felipe F. Casanueva · Manel Esteller · Manel Esteller
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer Siker Kimbung · Ching-Yi Chang · Pär-Ola Bendahl · Laura G. Dubois · J. Will Thompson · Donald P. McDonnell · Signe Borgquist · Signe Borgquist
Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinoma Trynke van der Boom · Esther N. Klein Hesselink · Hilde A. M. Kooistra · Karina Meijer · Anouk N. A. van der Horst-Schrivers · Joop D. Lefrandt · Thera P. Links · Thera P. Links
Dynamic risk stratification in the follow-up of thyroid cancer: what is still to be discovered in 2017? Jolanta Krajewska · Ewa Chmielik · Barbara Jarząb · Barbara Jarząb
Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma André Wendindondé Nana · Yu Tang Chin · Chi Yu Lin · Yih Ho · James Bennett · Ya Jung Shih · Yi Ru Chen · Chun A. Changou · Jens Z. Pedersen · Sandra Incerpi · Leroy F. Liu · Jacqueline Whang-Peng · Earl Fu · Wen Shan Li · Wen Shan Li · Shaker A. Mousa · Hung Yun Lin · Paul J. Davis · Paul J. Davis
Receptor activities of persistent pollutant serum mixtures and breast cancer risk Simon Garinet · Juliette Nectoux · M. Neou · Eric Pasmant · Anne Jouinot · Mathilde Sibony · Lucie Orhant · Juliana Pipoli da Fonseca · Karine Perlemoine · Léopoldine Bricaire · Lionel Groussin · Olivier Soubrane · Bertrand Dousset · Rossella Libé · Franck Letourneur · Jérôme Bertherat · Guillaume Assié · Guillaume Assié
Molecular and phenotypic evaluation of a novel germline TMEM127 mutation with an uncommon clinical presentation Fidéline Bonnet-Serrano · Jérôme Bertherat · Jérôme Bertherat
The microbiome in PTEN hamartoma tumor syndrome Livia Lamartina · Giorgio Grani · Emanuela Arvat · Alice Nervo · Maria Chiara Zatelli · Roberta Elisa Rossi · Efisio Puxeddu · Silvia Morelli · Massimo Torlontano · Michela Massa · Rocco Domenico Alfonso Bellantone · Alfredo Pontecorvi · Teresa Montesano · Loredana Pagano · Lorenzo Daniele · Laura Fugazzola · Graziano Ceresini · Rocco Bruno · R. Rossetto · Salvatore Tumino · Marco Centanni · Domenico Meringolo · Maria Grazia Castagna · Domenico Salvatore · Antonio Nicolucci · Giuseppe Lucisano · Sebastiano Filetti · Cosimo Durante · Cosimo Durante
Endocrine side effects of cancer immunotherapy Vincenzo Marotta · Maria Chiara Zatelli · Concetta Sciammarella · Maria Rosaria Ambrosio · Marta Bondanelli · Annamaria Colao · Antongiulio Faggiano · Antongiulio Faggiano
Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum Tiffany Scully · Carolyn D. Scott · Sue M. Firth · Lisa M. Sedger · John E. Pintar · Stephen M. Twigg · Robert C. Baxter · Robert C. Baxter
Nfe2l1-silenced insulinoma cells acquire aggressiveness and chemoresistance Victoria Byrd · Victoria Byrd · Ted M Getz · Ted M Getz · Roshan Padmanabhan · Hans Arora · Charis Eng · Charis Eng
Structure and function of RET in multiple endocrine neoplasia type 2 Ylenia Capodanno · Floryne O. Buishand · Lisa Y. Pang · Jolle Kirpensteijn · J.A. Mol · David Argyle · David Argyle
Mitochondrial topoisomerase I absence enhances aerobic glycolysis in cancer Andreas Machens · Henning Dralle · Henning Dralle
Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors Paula Fontes Asprino · Rudinei Diogo Marques Linck · Jonatas Cesar · Florêncio Porto Freitas · Fernanda Christtanini Koyama · Rachel P. Riechelmann · Frederico Costa · Paulo M. Hoff · Pedro A. F. Galante · Diogo Meyer · Anamaria A. Camargo · Jorge Sabbaga · Jorge Sabbaga
Patient quality of life and prognosis in multiple endocrine neoplasia type 2 Willem E. Corver · Joris Demmers · Jan Oosting · Shima Sahraeian · Arnoud Boot · Dina Ruano · Tom van Wezel · Hans Morreau · Hans Morreau
SDHA mutated paragangliomas may be at high risk of metastasis Nicola Tufton · Rahul Ghelani · Umasuthan Srirangalingam · Ajith Kumar · William Drake · Donato Iacovazzo · Kassiani Skordilis · Daniel M. Berney · M Al‐Mrayat · Bernard Khoo · Bernard Khoo
Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model Francesca Marano · Roberto Frairia · Letizia Rinella · Monica Argenziano · Benedetta Bussolati · Cristina Grange · Raffaella Mastrocola · Isabella Castellano · Laura Berta · Roberta Cavalli · Maria Graziella Catalano · Maria Graziella Catalano
The future: diagnostic and imaging advances in MEN1 therapeutic approaches and management strategies Jerena Manoharan · Max Albers · Detlef K. Bartsch · Detlef K. Bartsch
Association between changes in fat distribution and biomarkers for breast cancer Willemijn A.M. van Gemert · Evelyn M. Monninkhof · Anne M. May · Sjoerd G. Elias · Job van der Palen · Job van der Palen · Wouter B. Veldhuis · Maaike Stapper · Rebecca K. Stellato · Jantine A. Schuit · Petra H. Peeters · Petra H. Peeters · Petra H. Peeters
Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours Paola Romeo · Carla Colombo · Roberta Granata · Giuseppina Calareso · Ambra Vittoria Gualeni · Matteo Dugo · Loris De Cecco · Maria Grazia Rizzetti · Angela Zanframundo · Antonella Aiello · Maria Luisa Carcangiu · Annunziata Gloghini · Stefano Ferrero · Lisa Licitra · Angela Greco · Laura Fugazzola · Laura D. Locati · Maria Grazia Borrello · Maria Grazia Borrello
Hashimotos thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer Vincenzo Marotta · Concetta Sciammarella · Maria Grazia Chiofalo · Claudio Gambardella · Claudio Bellevicine · Marica Grasso · Giovanni Conzo · Giovanni Docimo · Gerardo Botti · Simona Losito · Giancarlo Troncone · Maurizio De Palma · Laura Giacomelli · Luciano Pezzullo · Annamaria Colao · Antongiulio Faggiano · Antongiulio Faggiano
Role of chromosomal instability in cancer progression Sarah E. McClelland · Sarah E. McClelland
Expression and mutational status of USP8 in tumors causing ectopic ACTH secretion syndrome Luis Gustavo Perez-Rivas · Andrea Oßwald · Thomas Knösel · Kristin Lucia · Christian Schaaf · Michael Hristov · Julia Fazel · Thomas Kirchner · Felix Beuschlein · Martin Reincke · Marily Theodoropoulou · Marily Theodoropoulou
A comprehensive review on MEN2B Frederic Castinetti · Jeffrey F. Moley · Lois M. Mulligan · Steven G. Waguespack · Steven G. Waguespack
Acromegaly is associated with increased cancer risk: a survey in Italy Massimo Terzolo · Giuseppe Reimondo · Paola Berchialla · Emanuele Ferrante · Elena Malchiodi · Laura De Marinis · Rosario Pivonello · S. Grottoli · Marco Losa · Salvatore Cannavò · Diego Ferone · Marcella Montini · Marta Bondanelli · Ernesto De Menis · Chiara Martini · Efisio Puxeddu · Antonino Velardo · Alessandro Peri · Marco Faustini-Fustini · P. Tita · Francesca Pigliaru · Giulia Peraga · Giorgio Borretta · Carla Scaroni · Nicoletta Bazzoni · Antonio Bianchi · Alessandro Berton · Andreea Serban · Roberto Baldelli · Letizia Maria Fatti · Annamaria Colao · Maura Arosio · Maura Arosio
Genetic and epigenetic drivers of neuroendocrine tumours (NET) Annunziata Di Domenico · Tabea Wiedmer · Ilaria Marinoni · Aurel Perren · Aurel Perren
Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance Catherine Zabkiewicz · Jeyna Resaul · Rachel Hargest · Wen Guo Jiang · Lin Ye · Lin Ye
Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) database Patrick Petrossians · Adrian Daly · Emil Natchev · Luigi Maione · Karin Blijdorp · Mouna Sahnoun Fathallah · Renata S. Auriemma · Alpha Mamadou Diallo · Anna-Lena Hulting · Diego Ferone · Vaclav Hana · Silvia Filipponi · Caroline Sievers · Claudia Nogueira · Carmen Fajardo Montañana · Davide Carvalho · Günter K. Stalla · Marie-Lise Jaffrain-Rea · B. Delemer · Annamaria Colao · Thierry Brue · Sebastian Neggers · Sabina Zacharieva · Philippe Chanson · Albert Beckers · Albert Beckers
Animal models of MEN 1 Hermine Mohr · Natalia S. Pellegata · Natalia S. Pellegata
Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas Masanori Murakami · Takanobu Yoshimoto · Kazuhiko Nakabayashi · Yujiro Nakano · Takahiro Fukaishi · Kyoichiro Tsuchiya · Isao Minami · Ryotaro Bouchi · Kohji Okamura · Yasuhisa Fujii · Koshi Hashimoto · Ken Ichiro Hata · Kazunori Kihara · Yoshihiro Ogawa · Yoshihiro Ogawa
STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance Praveena S. Thiagarajan · Praveena S. Thiagarajan · Qiao Zheng · Manvir Bhagrath · Erin E. Mulkearns-Hubert · Martin G Myers · Justin D. Lathia · Justin D. Lathia · Ofer Reizes · Ofer Reizes · Ofer Reizes
A case of a metastatic SDHA mutated paraganglioma re-presenting twenty-three years after initial surgery Ruth Casey · Benjamin G. Challis · Alison Marker · Deborah Pitfield · Heok Cheow · Ashley Shaw · Soo-Mi Park · Helen Simpson · Eamonn R. Maher · Eamonn R. Maher
Management impact: effects on quality of life and prognosis in MEN1 Francesca Marini · Francesca Giusti · Francesco Tonelli · Maria Luisa Brandi · Maria Luisa Brandi
The future: medical advances in MEN1 therapeutic approaches and management strategies Rachel S. van Leeuwaarde · Joanne M. de Laat · Carolina R. C. Pieterman · Koen M.A. Dreijerink · Menno R. Vriens · Gerlof D. Valk · Gerlof D. Valk
Prkar1a gene knockout in the pancreas leads to neuroendocrine tumorigenesis Emmanouil Saloustros · Paraskevi Salpea · Matthew F. Starost · Sisi Liu · Fabio R. Faucz · Edra London · Eva Szarek · Woo Jin Song · Mehboob A. Hussain · Constantine A. Stratakis · Constantine A. Stratakis
The role of the tumour microenvironment in immune therapy Stephan Gasser · Lina H.K. Lim · Florence Shin Gee Cheung · Florence Shin Gee Cheung
Consequences of mitotic slippage for antimicrotubule drug therapy Bing Cheng · Karen Crasta · Karen Crasta
Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo Misu Lee · Ninelia Minaskan · Tobias Wiedemann · Martin Irmler · Johannes Beckers · Behrooz H. Yousefi · Georgios Kaissis · Rickmer Braren · Iina Laitinen · Natalia S. Pellegata · Natalia S. Pellegata
Testicular vs adrenal sources of hydroxy-androgens in prostate cancer Tianzhu Zang · Mary-Ellen Taplin · Daniel Tamae · Wanling Xie · Clementina Mesaros · Zhenwei Zhang · Glenn J. Bubley · Bruce Montgomery · Steven P. Balk · Elahe A. Mostaghel · Ian A. Blair · Trevor M. Penning · Trevor M. Penning
De novo mutation in MEN1 is not associated with parental somatic mosaicism Yael Laitman · Anat Jaffe · Hagit Schayek · Eitan Friedman · Eitan Friedman
Centrosome amplification: a suspect in breast cancer and racial disparities Angela Ogden · Padmashree C.G. Rida · Ritu Aneja · Ritu Aneja
KIF1B and NF1 are the most frequently mutated genes in paraganglioma tumors Lucie Evenepoel · Raphaël Helaers · Laurent Vroonen · Selda Aydin · Marc Hamoir · Dominique Maiter · Miikka Vikkula · Alexandre Persu · Alexandre Persu
Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms Roberto Valente · Alastair Hayes · Sven-Petter Haugvik · Per Hedenström · Darko Siuka · Emilie Korsæth · Daniel Kämmerer · Stuart Robinson · Patrick Maisonneuve · Gianfranco Delle Fave · Björn Lindkvist · Gabriele Capurso · Gabriele Capurso
SDHB mutation carriers with malignant pheochromocytoma respond better to CVD Lauren Fishbein · Sivan Ben-Maimon · Stephen M. Keefe · Keith A. Cengel · Daniel A. Pryma · Arturo Loaiza-Bonilla · Douglas L. Fraker · Katherine L. Nathanson · Debbie L. Cohen · Debbie L. Cohen
Rationale for the development of alternative forms of androgen deprivation therapy Sangeeta Kumari · Dhirodatta Senapati · Hannelore V. Heemers · Hannelore V. Heemers
Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushings disease Laura C. Hernández-Ramírez · Nuria Valdés · Nuria Valdés · Maya Lodish · Nathan Pankratz · Aurelio Balsalobre · Yves Gauthier · Fabio R. Faucz · Giampaolo Trivellin · Prashant Chittiboina · John Lane · Denise M. Kay · Aggeliki Dimopoulos · Stephan Gaillard · M. Neou · Jérôme Bertherat · Guillaume Assié · Chiara Villa · Chiara Villa · James L. Mills · Jacques Drouin · Constantine A. Stratakis · Constantine A. Stratakis
Animal models of medullary thyroid cancer: state of the art and view to the future Giovanni Vitale · Germano Gaudenzi · Luisa Circelli · Marco Manzoni · Andrea Bassi · Niccolò Fioritti · Antongiulio Faggiano · Annamaria Colao · Annamaria Colao
Targeting mitotic pathways for endocrine-related cancer therapeutics Shivangi Agarwal · Dileep Varma · Dileep Varma
Estradiol for the mitigation of adverse effects of androgen deprivation therapy Nicholas Russell · Ada S Cheung · Mathis Grossmann · Mathis Grossmann
The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations Frederic Castinetti · Ana Luiza Maia · Mariola Pęczkowska · Marta Barontini · Kornelia Hasse-Lazar · Thera P. Links · Rodrigo A. Toledo · Sarka Dvorakova · Caterina Mian · Maria João Bugalho · Stefania Zovato · Maria Alevizaki · Andrei Kvachenyuk · Birke Bausch · Paola Loli · Simona R. Bergmann · Attila Patócs · Marija Pfeifer · Josefina Biarnes Costa · Ernst von Dobschuetz · Claudio Letizia · Gerlof D. Valk · Marcin Barczyński · Małgorzata Czetwertyńska · John Plukker · Paola Sartorato · Tomas Zelinka · Petr Vlcek · Svetlana Yaremchuk · Georges Weryha · Letizia Canu · Nelson Wohllk · F. Sebag · Martin K. Walz · Charis Eng · Hartmut P. H. Neumann · Hartmut P. H. Neumann
A role for TET2 in parathyroid carcinoma Elham Barazeghi · Anthony J. Gill · Stan B. Sidhu · Olov Norlén · Olov Norlén · Roberto Dina · Fausto Palazzo · Per Hellman · Peter Stålberg · Gunnar Westin · Gunnar Westin
Lessons from Bacterial Homolog of Tubulin, FtsZ for Microtubule Dynamics Rachana Rao Battaje · Dulal Panda · Dulal Panda
A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors Jan P. Dumanski · Chiara Rasi · Peyman Björklund · Hanna Davies · Abir Salwa Ali · Malin Grönberg · Staffan Welin · Halfdan Sorbye · Henning Grønbæk · Janet L. Cunningham · Lars Forsberg · Lars Lind · Erik Ingelsson · Peter Stålberg · Per Hellman · Eva Tiensuu Janson · Eva Tiensuu Janson
Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas Robert Formosa · Joseph A. Borg · Josanne Vassallo · Josanne Vassallo
Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF Waraporn Imruetaicharoenchoke · Alice Fletcher · Wenli Lu · Rachel Watkins · Bhavika Modasia · Vikki Poole · Hannah Nieto · Rebecca Thompson · Kristien Boelaert · Martin Read · Vicki Smith · Christopher J. McCabe · Christopher J. McCabe
Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms Hiroshi Imaoka · Mitsuhito Sasaki · Hideaki Takahashi · Yusuke Hashimoto · Izumi Ohno · Shuichi Mitsunaga · Kazuo Watanabe · Kumiko Umemoto · Gen Kimura · Yuko Suzuki · Masafumi Ikeda · Masafumi Ikeda
In memoriam: Dirk J Kwekkeboom (1958–2017) Wouter W. de Herder · E.P. Krenning · Gabriel P Krestin · Gabriel P Krestin
Vitamin D mitigates the adverse effects of obesity on breast cancer in mice Srilatha Swami · Aruna V. Krishnan · Jasmaine Williams · Abhishek Aggarwal · Megan A. Albertelli · Ronald L. Horst · Brian J. Feldman · David Feldman · David Feldman
Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells Francesco Caiazza · Alyson Murray · Stephen F. Madden · Naoise C Synnott · Elizabeth J. Ryan · Norma O’Donovan · John Crown · Michael J. Duffy · Michael J. Duffy
WOMEN IN CANCER PROFILE: My pathway to understanding the role of the tumour microenvironment in cancer progression Angela H Ting · Angela H Ting
Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptor Li Zeng · Hanna A Zielinska · Azeem Arshad · Julian Shield · Amit Bahl · Jeffrey M P Holly · Claire M Perks · Claire M Perks
FOXO factors and breast cancer: outfoxing endocrine resistance Martyn Bullock · Martyn Bullock
Hyperplasia in glands with hormone excess Stephen J. Marx · Stephen J. Marx
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer Jan Kroon · Martin Puhr · Jeroen T. Buijs · Geertje van der Horst · Daniëlle M Hemmer · Koen A Marijt · Ming S Hwang · Motasim Masood · Stefan Grimm · Gert Storm · Josbert M. Metselaar · Onno Meijer · Zoran Culig · Gabri van der Pluijm · Gabri van der Pluijm
Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model Jeong Won Park · Cho Rong Han · Li Zhao · Mark C. Willingham · Sheue-yann Cheng · Sheue-yann Cheng
Evidence for a heritable contribution to neuroendocrine tumors of the small intestine Deborah W. Neklason · James VanDerslice · Karen Curtin · Lisa A. Cannon-Albright · Lisa A. Cannon-Albright
Functional characterization of multiple DICER1 mutations in an adolescent Mona Wu · L de Kock · Louise S. Conwell · Colin J.R. Stewart · Bruce R. King · Catherine S. Choong · K Hussain · Nelly Sabbaghian · Ian J. MacRae · M R Fabian · William D. Foulkes · William D. Foulkes
Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma Luiz Gustavo A Chuffa · Michelly S Alves · Marcelo Martinez · Isabel Cristina C Camargo · Patricia F F Pinheiro · Raquel F Domeniconi · Luiz Antonio Lupi Júnior · F. E. Martinez · F. E. Martinez
In vitro transforming potential, intracellular signaling properties and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu and Arg886Trp Hugo Prazeres · Hugo Prazeres · Joana Couto · Fernando Rodrigues · João Vinagre · Joana Torres · Vítor Trovisco · Teresa Martins · Manuel Sobrinho-Simões · Manuel Sobrinho-Simões · Paula Soares · Paula Soares · Paula Soares
Targeting muscle signaling pathways to minimize adverse effects of androgen deprivation Casey de Rooy · Mathis Grossmann · Jeffrey D. Zajac · Ada S Cheung · Ada S Cheung
A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells Arvind Thakkar · Ahmed Aljameeli · Shibu Thomas · Girish V. Shah · Girish V. Shah
NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cells Toru Tateno · Tae Nakano-Tateno · Shereen Ezzat · Sylvia L Asa · Sylvia L Asa
Anti-inflammatory therapies in TRAMP mice: delay in PCa progression Larissa Akemi Kido · Fabio Montico · Rafael Sauce · Aline Barbosa Macedo · Elaine Minatel · Débora Barbosa Vendramini Costa · João Ernesto de Carvalho · Ronaldo Aloise Pilli · Valéria Helena Alves Cagnon · Valéria Helena Alves Cagnon
TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids Samah Rafehi · Yudith Ramos Valdes · Monique Bertrand · Jacob McGee · Michel Prefontaine · Akira Sugimoto · Gabriel E. DiMattia · Trevor G. Shepherd · Trevor G. Shepherd
Predictive factors of response to mTOR inhibitors in neuroendocrine tumours Maria Chiara Zatelli · Giuseppe Fanciulli · Pasqualino Malandrino · Valeria Ramundo · Antongiulio Faggiano · Annamaria Colao · Annamaria Colao
CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma Sun Wook Cho · Young Ae Kim · Hyun Jin Sun · Ye An Kim · Byung-Chul Oh · Ka Hee Yi · Do Joon Park · Young Joo Park · Young Joo Park
Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study Martyn Caplin · Marianne Pavel · Jarosław B. Ćwikła · Alexandria T. Phan · Markus Raderer · Eva Sedláčková · Guillaume Cadiot · Edward M. Wolin · Jaume Capdevila · Lucy Wall · Guido Rindi · Alison Langley · Séverine Martinez · Edda Gomez-Panzani · Philippe Ruszniewski · Philippe Ruszniewski
Androgen control of lipid metabolism in prostate cancer: novel insights and future applications Lisa M. Butler · Margaret M. Centenera · Johannes V. Swinnen · Johannes V. Swinnen
HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma Zhengping Zhuang · Chunzhang Yang · Ales Ryska · Yuan Ji · Yingyong Hou · Sky D Graybill · Petra Bullova · Petra Bullova · Irina A. Lubensky · Günter Klöppel · Karel Pacak · Karel Pacak
A phase II study of axitinib in advanced neuroendocrine tumors Jonathan R. Strosberg · Mauro Cives · Jimmy Hwang · T Weber · M Nickerson · Chloe Evelyn Atreya · Alan P. Venook · T Valone · Brian Morse · D. Coppola · Emily K. Bergsland · Emily K. Bergsland
Clonal origin and spread of metastatic prostate cancer Jamie L. Van Etten · Scott M. Dehm · Scott M. Dehm
Identification of signaling pathways associated with cancer protection in Laron syndrome Lena Lapkina-Gendler · Itai Rotem · Metsada Pasmanik-Chor · David Gurwitz · Rive Sarfstein · Zvi Laron · Haim Werner · Haim Werner
Serendipity and purpose Nancy E. Davidson · Nancy E. Davidson
Role of Protein S in castration-resistant prostate cancer-like cells Peng Ning · Jia-guo Zhong · Fan Jiang · Yi Zhang · Jie Zhao · Feng Tian · Wei Li · Wei Li
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice Zara Zelenko · Emily Jane Gallagher · Irini Markella Antoniou · Deepali Sachdev · Anupma Nayak · Douglas Yee · Derek LeRoith · Derek LeRoith
PYK2 via S6K1 regulates the function of androgen receptors and the growth of prostate cancer cells Yu-Hsuan Hsiao · Yu-Ting Huang · Chia-Yu Hung · Tzu-Chien Kuo · Fuh-Jinn Luo · Ta-Chun Yuan · Ta-Chun Yuan
WOMEN IN CANCER PROFILE: From physics to cancer biology and everywhere in between Paramita M. Ghosh · Paramita M. Ghosh
mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors Simona Falletta · Stefano Partelli · Corrado Rubini · Dominik Nann · Andrea Doria · Ilaria Marinoni · Vanessa Polenta · Carmelina Di Pasquale · Ettore C. degli Uberti · Aurel Perren · Massimo Falconi · Maria Chiara Zatelli · Maria Chiara Zatelli
Patient-derived tumour xenografts for breast cancer drug discovery John W Cassidy · Ankita Sati Batra · Wendy Greenwood · Alejandra Bruna · Alejandra Bruna
In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production Kiyoshi Ito · Yasuhiro Miki · Takashi Suzuki · Keely May McNamara · Hironobu Sasano · Hironobu Sasano
cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors Graeme B. Bolger · Mariana Ferreira Bizzi · Sérgio Veloso Brant Pinheiro · Giampaolo Trivellin · Lisa Smoot · Mary-Ann Accavitti · Márta Korbonits · Antônio Ribeiro-Oliveira · Antônio Ribeiro-Oliveira
Primary cancer cell culture: mammary-optimized vs conditional reprogramming Ahmad M. Alamri · Ahmad M. Alamri · Keunsoo Kang · Svenja Groeneveld · Svenja Groeneveld · Weisheng Wang · Xiaogang Zhong · Bhaskar Kallakury · Lothar Hennighausen · Xuefeng Liu · Priscilla A. Furth · Priscilla A. Furth
New drugs for medullary thyroid cancer: new promises? Christine Spitzweg · John C. Morris · Keith C. Bible · Keith C. Bible
Evaluation of the methods to identify patients who may benefit from PARP inhibitor use Diana Lim · Joanne Ngeow · Joanne Ngeow
Recent incidences and differential trends of thyroid cancer in the USA Yushan Mao · Mingzhao Xing · Mingzhao Xing
In touch with your feminine side: how oestrogen metabolism impacts prostate cancer Habibur Rahman · Johannes Hofland · Paul A. Foster · Paul A. Foster
Insulin resistance as a predictor of venous thromboembolism in breast cancer Patrizia Ferroni · Mario Roselli · Silvia Riondino · Francesco Cavaliere · Fiorella Guadagni · Fiorella Guadagni
Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules Arivarasan Karunamurthy · Federica Panebianco · Susan J Hsiao · Jennie Vorhauer · Marina N. Nikiforova · Simion I. Chiosea · Yuri E. Nikiforov · Yuri E. Nikiforov
WOMEN IN CANCER THEMATIC REVIEW: Diverse functions of DNA methylation: implications for prostate cancer and beyond Thomas J Sweet · Angela H Ting · Angela H Ting
WOMEN IN CANCER PROFILE: From bedside to bench and back: my journey in thyroid disease Kristien Boelaert · Kristien Boelaert · Kristien Boelaert
Women in cancer profile: A gender agenda? Charlotte L. Bevan · Charlotte L. Bevan
WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer Ion Cristóbal · Blanca Torrejón · Manuel Pedregal · Federico Rojo · Jesús García-Foncillas · Jesús García-Foncillas
WOMEN IN CANCER THEMATIC REVIEW: Thyroid-stimulating hormone in thyroid cancer: does it matter? Chun-Peng Liao · Leng-Ying Chen · Andrea Luethy · Youngsoo Kim · Kian Kani · A. Robert MacLeod · Mitchell E. Gross · Mitchell E. Gross
Lessons learnt from outstanding mid-career women in endocrine cancer research Deborah J. Marsh · Charis Eng · Charis Eng
WOMEN IN CANCER PROFILE: Neuroendocrine tumors: moving from the land of small tumors to an expanding universe Marianne Pavel · Marianne Pavel
Pushing estrogen receptor around in breast cancer Elgene Lim · Gerard A. Tarulli · Neil Portman · Theresa E. Hickey · Wayne D. Tilley · Carlo Palmieri · Carlo Palmieri
E2F1-mediated human POMC expression in ectopic Cushings syndrome Takako Araki · Ning-Ai Liu · Yukiko Tone · Daniel Cuevas-Ramos · Roy Heltsley · Masahide Tone · Shlomo Melmed · Shlomo Melmed
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence Isabel Coutinho · Tanya K. Day · Wayne D. Tilley · Luke A. Selth · Luke A. Selth
Novel twists in hormone-mediated carcinogenesis Wayne D. Tilley · Wayne D. Tilley
Emerging data on androgen receptor splice variants in prostate cancer Subing Cao · Yang Zhan · Yan Dong · Yan Dong
Familial non-medullary thyroid cancer: unraveling the genetic maze Samantha Peiling Yang · Joanne Ngeow · Joanne Ngeow
Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future Kjell K. Öberg · Steven W. J. Lamberts · Steven W. J. Lamberts
The endocrine influence on the bone microenvironment in early breast cancer Caroline Wilson · Hannah K. Brown · Ingunn Holen · Ingunn Holen
WOMEN IN CANCER THEMATIC REVIEW: Systemic therapies in neuroendocrine tumors and novel approaches toward personalized medicine Marianne Pavel · Christine Sers · Christine Sers
Growth hormone and risk for cardiac tumors in Carney complex W. Patricia Bandettini · Alexander S. Karageorgiadis · Ninet Sinaii · Douglas R. Rosing · Vandana Sachdev · Marie Helene Schernthaner-Reiter · Evgenia Gourgari · Georgios Z. Papadakis · Meg Keil · Charalampos Lyssikatos · J.Aidan Carney · Andrew E. Arai · Maya Lodish · Constantine A. Stratakis · Constantine A. Stratakis
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas Sara G Creemers · P. M. van Koetsveld · F. J. van Kemenade · Thomas G. Papathomas · G J H Franssen · Fadime Dogan · E M W Eekhoff · P van der Valk · W. W. de Herder · Joseph A M J L Janssen · Richard A. Feelders · Leo J. Hofland · Leo J. Hofland
Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review Sakine Sever · Donna L. White · Jose M. Garcia · Jose M. Garcia
Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers Roger L. Milne · Antonis C. Antoniou · Antonis C. Antoniou
Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers Louis de Mestier · Jean-Baptiste Danset · Cindy Neuzillet · Vinciane Rebours · Jérôme Cros · Nadem Soufir · Pascal Hammel · Pascal Hammel
Synthetic lethality: the road to novel therapies for breast cancer Kiranjit K. Dhillon · Ilirjana Bajrami · Toshiyasu Taniguchi · Christopher J. Lord · Christopher J. Lord
BRCA2 functions: from DNA repair to replication fork stabilization Amélie Fradet-Turcotte · Justine Sitz · Damien Grapton · Alexandre Orthwein · Alexandre Orthwein
Targeting CDK9: a promising therapeutic opportunity in prostate cancer Muhammed H. Rahaman · Malika Kumarasiri · Laychiluh B. Mekonnen · Mingfeng Yu · Sarah Diab · Hugo Albrecht · Robert W. Milne · Shudong Wang · Shudong Wang
Perspectives for immunotherapy in endocrine cancer Soeren Latteyer · Vera Tiedje · Bastian Schilling · Dagmar Führer · Dagmar Führer
Redefining the origin and evolution of ovarian cancer: a hormonal connection Carlos Cardenas · Ayesha B. Alvero · Bo Seong Yun · Gil Mor · Gil Mor
Genetics of primary hyperaldosteronism Ravi Kumar Dutta · Peter Söderkvist · Oliver Gimm · Oliver Gimm
Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study Yeting Du · Monica Ter-Minassian · Monica Ter-Minassian · Lauren K. Brais · Nichole V. Brooks · Amanda Waldron · Jennifer A. Chan · Xihong Lin · Peter Kraft · David C. Christiani · Matthew H. Kulke · Matthew H. Kulke
Uncontrolled diabetes predicts poor response to novel antiandrogens Theodoros Karantanos · Styliani Karanika · Gretchen A. Gignac · Gretchen A. Gignac
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features Pedro Weslley Rosario · Gabriela Franco Mourão · Maurício Nunes · Marcelo Saldanha Nunes · Maria Regina Calsolari · Maria Regina Calsolari
BRCA2: a grown-up cancer susceptibility gene William D. Foulkes · Kokichi Sugano · Kokichi Sugano
Defects in homologous recombination repair behind the human diseases: FA and HBOC Yoko Katsuki · Minoru Takata · Minoru Takata
WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of clock genes on prostate cancer Zsofia Kiss · Paramita M. Ghosh · Paramita M. Ghosh
Plasma membrane ion channels and epithelial to mesenchymal transition in cancer cells Iman Azimi · Gregory R. Monteith · Gregory R. Monteith
Modeling estrogen receptor-positive breast cancers in mice: is it the best we can do? Ioulia Chatzistamou · Hippokratis Kiaris · Hippokratis Kiaris
Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases Ju-Yeon Moon · Man Ho Choi · Jayoung Kim · Jayoung Kim
Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel Benjamin Thomas · Jonathan Kay · Suraj Menon · Sarah L. Vowler · Sarah Dawson · Laura J Bucklow · Hayley Luxton · Thomas Johnston · Charlie E. Massie · Michelle Pugh · Anne Warren · Peter Barker · Keith Burling · Andy G. Lynch · Anne George · Johanna Burge · Marie Corcoran · Sara Stearn · Alastair D. Lamb · Naomi L. Sharma · Greg Shaw · David E. Neal · Hayley C. Whitaker · Hayley C. Whitaker
Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk Allison Sumis · Katherine L. Cook · Fabia O Andrade · Fabia O Andrade · Rong Hu · Emma Kidney · Xiyuan Zhang · Dominic Kim · Elissa Carney · Nguyen Nguyen · Wei Yu · Kerrie B. Bouker · Idalia Cruz · Robert Clarke · Leena Hilakivi-Clarke · Leena Hilakivi-Clarke
A comparison of CellCollector with CellSearch in patients with neuroendocrine tumours Dalvinder Mandair · Clare Vesely · Leah Ensell · Helen Lowe · Victoria J. Spanswick · John A. Hartley · Martyn Caplin · Tim Meyer · Tim Meyer
TERT promoter mutations and long-term survival in patients with thyroid cancer Tae Hyuk Kim · Young-Eun Kim · Soomin Ahn · Ji-Youn Kim · Young Lyun Oh · Kyunga Kim · Jae Won Yun · Woong-Yang Park · Jun-Ho Choe · Jung-Han Kim · Jee Soo Kim · Sun Wook Kim · Jae Hoon Chung · Jae Hoon Chung
Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer Duane H. Hamilton · Mario Roselli · Patrizia Ferroni · Leopoldo Costarelli · Francesco Cavaliere · Mariateresa Taffuri · Claudia Palena · Fiorella Guadagni · Fiorella Guadagni
Genetic variants in thyroid cancer distant metastases Steven E. Justiniano · Joseph P. McElroy · Lianbo Yu · Ayse Selen Yilmaz · Kevin R. Coombes · Leigha Senter · Rebecca Nagy · Paul E. Wakely · Stefano Volinia · Michelle Vinco · Thomas J. Giordano · Carlo M. Croce · Motoyasu Saji · Matthew D. Ringel · Matthew D. Ringel · Matthew D. Ringel
Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer Aleksandra M. Ochnik · Robert C. Baxter · Robert C. Baxter
Appendiceal neuroendocrine neoplasms: diagnosis and management Krystallenia I. Alexandraki · Gregory Kaltsas · Simona Grozinsky-Glasberg · Eleftherios Chatzellis · Ashley B Grossman · Ashley B Grossman
WOMEN IN CANCER PROFILE: Dude, wheres my band? Tessa Brabander · Wouter A. van der Zwan · Jaap J.M. Teunissen · Boen L.R. Kam · Wouter W. de Herder · Richard A. Feelders · Eric P. Krenning · Dik J. Kwekkeboom · Dik J. Kwekkeboom
AI-related BMD variation in actual practice conditions: A prospective cohort study Maria Rodriguez-Sanz · D Prieto-Alhambra · Sonia Servitja · Natalia Garcia-Giralt · Laia Garrigos · Jaime Rodriguez-Morera · Joan Albanell · Maria Martinez-Garcia · Iria González · A Diez-Perez · Ignasi Tusquets · Xavier Nogués · Xavier Nogués
Glandular epithelial AR inactivation enhances PTEN deletion-induced uterine pathology Jaesung Peter Choi · Yu Zheng · David J. Handelsman · Ulla Simanainen · Ulla Simanainen
Hormone receptor status does not alter the effect of trastuzumab in breast cancer Tanja Ignatov · Holm Eggemann · Elke Burger · Serban-Dan Costa · Atanas Ignatov · Atanas Ignatov
Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation Vinciane Corman · Iulia Potorac · Florence Manto · Sarah Dassy · Karin Segers · Albert Thiry · Vincent Bours · Adrian Daly · Albert Beckers · Albert Beckers
Screening for GPR101 defects in pediatric pituitary corticotropinomas Giampaolo Trivellin · Ricardo Correa · Maria Batsis · Fabio R. Faucz · Prashant Chittiboina · Ivana Bjelobaba · Do Larco · Martha Quezado · Adrian Daly · Stanko S. Stojilkovic · T. John Wu · Albert Beckers · Maya Lodish · Constantine A. Stratakis · Constantine A. Stratakis
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects Adrian Daly · Bo Yuan · Frédéric Fina · Jean-Hubert Caberg · Giampaolo Trivellin · Liliya Rostomyan · Wouter W. de Herder · Luciana A. Naves · D Metzger · Thomas Cuny · Wolfgang Rabl · Nalini S. Shah · Marie-Lise Jaffrain-Rea · Maria Chiara Zatelli · Fabio R. Faucz · Emilie Castermans · Isabelle Nanni-Metellus · Maya Lodish · Ammar Muhammad · Leonor Palmeira · Iulia Potorac · Giovanna Mantovani · Sebastian Neggers · M. Klein · Anne Barlier · Pengfei Liu · L’Houcine Ouafik · Vincent Bours · James R. Lupski · Constantine A. Stratakis · Albert Beckers · Albert Beckers
FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion Veronica Kalhori · Melissa Magnusson · Muhammad Yasir Asghar · Ilari Pulli · Kid Törnquist · Kid Törnquist
MCM5 as a target of BET inhibitors in thyroid cancer cells Catia Mio · Elisa Lavarone · Ketty Conzatti · Federica Baldan · Barbara Toffoletto · Cinzia Puppin · Sebastiano Filetti · Cosimo Durante · Diego Russo · Arturo Orlacchio · Antonio Di Cristofano · Carla Loreto · Giuseppe Damante · Giuseppe Damante
Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model Hen Prizant · Manisha Taya · Irina Lerman · Allison Light · Aritro Sen · Soumya Mitra · Thomas H. Foster · Stephen R. Hammes · Stephen R. Hammes
ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo Yunhui Cheng · Raili Kerppola · Tom Klaus Kerppola · Tom Klaus Kerppola
Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia Sisi Liu · Emmanouil Saloustros · Annabel Berthon · Matthew F. Starost · Isabelle Sahut-Barnola · Paraskevi Salpea · Eva Szarek · Fabio R. Faucz · Antoine Martinez · Constantine A. Stratakis · Constantine A. Stratakis
Germline PARP4 mutations in patients with primary thyroid and breast cancers Yuji Ikeda · Kazuma Kiyotani · Poh Yin Yew · Taigo Kato · Kenji Tamura · Kai Lee Yap · Sarah M Nielsen · Jessica Mester · Charis Eng · Yusuke Nakamura · Raymon H. Grogan · Raymon H. Grogan
Prevalence and phenotypic characteristics of EIF1AX mutations in thyroid nodules Arivarasan Karunamurthy · Federica Panebianco · Susan Hsiao · Jennie Vorhauer · Marina N. Nikiforova · Simion I. Chiosea · Yuri E. Nikiforov · Yuri E. Nikiforov
Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression Pauline Croisé · Sébastien Houy · Mathieu Gand · Joël Lanoix · Valérie Calco · Petra Tóth · Laurent Brunaud · Sandra Lomazzi · Eustache Paramithiotis · Daniel Chelsky · Stéphane Ory · Stéphane Gasman · Stéphane Gasman
Lymphovascular invasion is associated with survival for papillary thyroid cancer Lauren N. Pontius · Linda Youngwirth · Samantha Thomas · Randall P. Scheri · Sanziana A. Roman · Julie Ann Sosa · Julie Ann Sosa
Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours Alexa Childs · Amy Kirkwood · Julien Edeline · Tu Vinh Luong · Jennifer Watkins · Angela Lamarca · Doraid Alrifai · Phyllis Nsiah-Sarbeng · Roopinder Gillmore · Astrid Mayer · Christina Thirlwell · Debashis Sarker · Juan W. Valle · Tim Meyer · Tim Meyer
MicroRNAs associated with small bowel neuroendocrine tumours and their metastases Helen C Miller · Adam E. Frampton · Anna Malczewska · Anna Malczewska · Silvia Ottaviani · Euan A. Stronach · Rashpal Flora · Daniel Kaemmerer · Gerd Schwach · Roswitha Pfragner · Omar Faiz · Beata Kos-Kudła · George B. Hanna · Justin Stebbing · Leandro Castellano · Andrea Frilling · Andrea Frilling
TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells Giuseppe Palladino · Tiziana Notarangelo · Giuseppe Pannone · Annamaria Piscazzi · Lorenza Sisinni · Girolamo Spagnoletti · Paolo Toti · Angela Santoro · Giovanni Storto · Pantaleo Bufo · Mauro Cignarelli · Franca Esposito · Matteo Landriscina · Matteo Landriscina
WNT4 mediates the autocrine effects of growth hormone in mammary carcinoma cells Cécile M. Vouyovitch · Jo K. Perry · Dong-Xu Liu · Laurent Bezin · Eric Vilain · Jean-Jacques Diaz · Peter E. Lobie · Hichem C. Mertani · Hichem C. Mertani
RET mutation and increased angiogenesis in medullary thyroid carcinomas Antonella Verrienti · Giovanni Tallini · Chiara Colato · Amélie Boichard · Saula Checquolo · Valeria Pecce · Marialuisa Sponziello · Francesca Rosignolo · Dario de Biase · Kerry J. Rhoden · Gian Piero Casadei · Diego Russo · Michela Visani · Giorgia Acquaviva · M Ferdeghini · Sebastiano Filetti · Cosimo Durante · Cosimo Durante
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes Milena Rondón-Lagos · Nelson Rangel · Ludovica Verdun di Cantogno · Laura Annaratone · Isabella Castellano · Rosalia Russo · Tilde Manetta · Caterina Marchiò · Anna Sapino · Anna Sapino
Risk factors for subsequent endocrine-related cancer in childhood cancer survivors Mark Wijnen · Mark Wijnen · M.M. van den Heuvel-Eibrink · M Medici · Robin P. Peeters · A. J. van der Lely · Sebastian Neggers · Sebastian Neggers · Sebastian Neggers
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells Thomas Cuny · Caroline Zeiller · Martin Bidlingmaier · Céline Defilles · Catherine Roche · Marie-Pierre Blanchard · Marily Theodoropoulou · Thomas Graillon · Morgane Pertuit · Dominique Figarella-Branger · Alain Enjalbert · Thierry Brue · Anne Barlier · Anne Barlier
Metabolic history impacts mammary tumor epithelial hierarchy and early drug response in mice Maria Theresa E. Montales · Stepan Melnyk · Shi J Liu · Frank A. Simmen · Y Lucy Liu · Rosalia C. M. Simmen · Rosalia C. M. Simmen
SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model Xuguang Zhu · Dong Wook Kim · Li Zhao · Mark C. Willingham · Sheue-yann Cheng · Sheue-yann Cheng
High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy Bertrand Brieau · Olivia Hentic · Rachida Lebtahi · Maxime Palazzo · Makrem Ben Reguiga · Vinciane Rebours · Frédérique Maire · Pascal Hammel · Philippe Ruszniewski · Pierre Fenaux · Pierre Fenaux
MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors Jérôme Cros · Olivia Hentic · Vinciane Rebours · Magaly Zappa · N Gille · N Theou-Anton · D Vernerey · Frédérique Maire · Philippe Lévy · Pierre Bedossa · V Paradis · Pascal Hammel · Philippe Ruszniewski · Anne Couvelard · Anne Couvelard
Endocrine tumors associated with the vagus nerve Arthur Varoquaux · Electron Kebebew · F. Sebag · Katherine I. Wolf · Jean-François Henry · Karel Pacak · David Taïeb · David Taïeb
Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies Conleth G. Murphy · Maura N. Dickler · Maura N. Dickler · Maura N. Dickler
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair Andrea Perra · Michelina Plateroti · Amedeo Columbano · Amedeo Columbano
Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche Hyun Ho Han · Baek Gil Kim · Joo Hyun Lee · Suki Kang · Ji Eun Kim · Nam Hoon Cho · Nam Hoon Cho
ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer Laura A Baker · Holly Holliday · Alexander Swarbrick · Alexander Swarbrick
Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation Gabriela Franco Mourão · Pedro Weslley Rosario · Maria Regina Calsolari · Maria Regina Calsolari
Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma Seo Ki Kim · Jung-Woo Woo · Jun Ho Lee · Inhye Park · Jun-Ho Choe · Jung-Han Kim · Jee Soo Kim · Jee Soo Kim
Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials Laisa Teleni · Raymond Javan Chan · Alexandre Chan · Elisabeth Isenring · Ian Vela · Warrick J. Inder · Alexandra L. McCarthy · Alexandra L. McCarthy
Methylated circulating tumor DNA in blood: power in cancer prognosis and response Kristina Warton · Kate Lynette Mahon · Goli Samimi · Goli Samimi
Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism? Carole Guerin · David Taieb · Giorgio Treglia · Thierry Brue · André Lacroix · Frederic Sebag · Frederic Castinetti · Frederic Castinetti
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours Eleonora Vitali · Valeria Cambiaghi · Alessandro Zerbi · Carlo Carnaghi · Piergiuseppe Colombo · Erika Peverelli · Anna Spada · Giovanna Mantovani · Andrea Lania · Andrea Lania
TERT promoter mutations in thyroid cancer Rengyun Liu · Mingzhao Xing · Mingzhao Xing
Tumor progression, metastasis, and modulators of epithelial–mesenchymal transition in endometrioid endometrial carcinoma: an update Annu Makker · Madhu Mati Goel · Madhu Mati Goel
Effectiveness of chemotherapy in advanced differentiated thyroid cancer: a systematic review Ana Albero · Juliana Ester Lopéz · Alberto Torres · Luis de la Cruz · Tomas Martin · Tomas Martin
GHRH excess and blockade in X-LAG syndrome Adrian Daly · Philippe A. Lysy · Céline Desfilles · Liliya Rostomyan · Amira Mohamed · Jean-Hubert Caberg · Veronique Raverot · Emilie Castermans · Etienne Marbaix · Dominique Maiter · Chloé Brunelle · Giampaolo Trivellin · Constantine A. Stratakis · Vincent Bours · Christian Raftopoulos · Véronique Beauloye · Anne Barlier · Albert Beckers · Albert Beckers
Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten+/− mice Marta Vaquero · Anna Macià · Carlos Anerillas · Ana Velasco · Xavier Matias-Guiu · Joan Ribera · Mario Encinas · Mario Encinas
MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma Mirian Romitti · Simone Magagnin Wajner · Lucieli Ceolin · Carla Vaz Ferreira · Rafaela Vanin Pinto Ribeiro · Helena Cecin Rohenkohl · Shana de Souto Weber · Patrícia Luciana da Costa Lopez · Cesar Seigi Fuziwara · Edna Teruko Kimura · Ana Luiza Maia · Ana Luiza Maia
AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells Anne-Lise Lecoq · Anne-Lise Lecoq · Say Viengchareun · Say Viengchareun · Mirella Hage · Mirella Hage · Jérôme Bouligand · Jérôme Bouligand · Jacques Young · Jacques Young · Audrey Boutron · Philippe Zizzari · Marc Lombès · Marc Lombès · Philippe Chanson · Philippe Chanson · Peter Kamenický · Peter Kamenický · Peter Kamenický
PVALB diminishes [Ca2+] and alters mitochondrial features in follicular thyroid carcinoma cells through AKT/GSK3β pathway Thais Biude Mendes · Bruno Heidi Nakano Nozima · Alexandre Budu · Rodrigo Souza · Marcia Helena Braga Catroxo · Rosana Delcelo · Marcos L. Gazarini · Janete M. Cerutti · Janete M. Cerutti
The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1 Birgit Luef · Florian Handle · Gvantsa Kharaishvili · Martina Hager · Johannes Rainer · Günter Janetschek · Stephan Hruby · Christine Englberger · Jan Bouchal · Frédéric R. Santer · Zoran Culig · Zoran Culig
Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma Seo Ki Kim · Jung-Woo Woo · Jun Ho Lee · Inhye Park · Jun-Ho Choe · Jung-Han Kim · Jee Soo Kim · Jee Soo Kim
Treatment of advanced thyroid cancer with targeted therapies: ten years of experience David Viola · Laura Valerio · Eleonora Molinaro · Laura Agate · Valeria Bottici · Agnese Biagini · Loredana Lorusso · Virginia Cappagli · Letizia Pieruzzi · Carlotta Giani · Elena Sabini · Paolo Passannati · Luciana Puleo · Antonio Matrone · Benedetta Pontillo-Contillo · Valentina Battaglia · Salvatore Mazzeo · Paolo Vitti · Rossella Elisei · Rossella Elisei
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma Sara G Creemers · Leo J. Hofland · Esther Korpershoek · G J H Franssen · F. J. van Kemenade · W. W. de Herder · Richard A. Feelders · Richard A. Feelders
WOMEN IN CANCER THEMATIC REVIEW: Ovarian cancer–peritoneal cell interactions promote extracellular matrix processing Carmela Ricciardelli · Noor A. Lokman · Miranda P. Ween · Martin K. Oehler · Martin K. Oehler
ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy Patricia V. Elizalde · Rosalía I Cordo Russo · María F. Chervo · Roxana Schillaci · Roxana Schillaci
M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds M. Cecilia Martins-Costa · Lucas Leite Cunha · Susan C. Lindsey · Cléber P. Camacho · Renata P. Dotto · Gilberto K. Furuzawa · M Sharmila A Sousa · Teresa S. Kasamatsu · Ilda S. Kunii · Márcio M Martins · Alberto L. Machado · João Roberto Maciel Martins · Magnus R. Dias-da-Silva · Rui M. B. Maciel · Rui M. B. Maciel
Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome Roland Därr · Joan Nambuba · Jaydira Del Rivero · Ingo Janssen · Maria J. Merino · Milena Todorovic · Bela Balint · Ivana Jochmanova · Josef T. Prchal · Ronald M. Lechan · Arthur S. Tischler · Vera Popovic · Dragana Miljic · Karen T. Adams · F Ryan Prall · Alexander Ling · Meredith R. Golomb · Michael J. Ferguson · Naris Nilubol · Clara C. Chen · Emily Y. Chew · David Taïeb · Constantine A. Stratakis · Tito Fojo · Chunzhang Yang · Electron Kebebew · Zhengping Zhuang · Karel Pacak · Karel Pacak
Application of molecular biology of differentiated thyroid cancer for clinical prognostication Vincenzo Marotta · Concetta Sciammarella · Annamaria Colao · Antongiulio Faggiano · Antongiulio Faggiano
Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours Georgios K. Dimitriadis · Georgios K. Dimitriadis · Martin O. Weickert · Martin O. Weickert · Harpal S. Randeva · Harpal S. Randeva · Gregory Kaltsas · Gregory Kaltsas · Gregory Kaltsas · Ashley B. Grossman · Ashley B. Grossman
Myeloid neoplasms after chemotherapy and PRRT: myth and reality Lisa Bodei · Irvin M. Modlin · Markus Luster · Flavio Forrer · Marta Cremonesi · Rodney J. Hicks · Samer Ezziddin · Mark Kidd · Arturo Chiti · Arturo Chiti
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors Mauro Cives · M Ghayouri · B Morse · M Brelsford · M Black · A Rizzo · Alan K. Meeker · Jonathan R. Strosberg · Jonathan R. Strosberg
Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma Sara Jung · Zoltán Lóránt Nagy · Martin Fassnacht · Gerard P. Zambetti · Max Weiss · Martin Reincke · Felix Beuschlein · Constanze Hantel · Constanze Hantel
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly Iulia Potorac · Patrick Petrossians · Adrian Daly · Orsalia Alexopoulou · Sophie Borot · Mona Sahnoun-Fathallah · Frederic Castinetti · Marie Lise Jaffrain-Rea · Claire Briet · Florina Luca · Marion Lapoirie · Flavius Zoicas · I. Simoneau · Alpha Mamadou Diallo · Ammar Muhammad · Fahrettin Kelestimur · Elena Nazzari · Rogelio Garcia Centeno · Susan M. Webb · Marie Laure Nunes · Vaclav Hana · Véronique Pascal-Vigneron · Irena Ilovayskaya · Farida Nasybullina · Samia Achir · Diego Ferone · Sebastian Neggers · B. Delemer · Jean Michel Petit · Christof Schöfl · Gérald Raverot · Bernard Goichot · Patrice Rodien · Bernard Corvilain · Thierry Brue · F. Schillo · Luaba Tshibanda · Dominique Maiter · Jean François Bonneville · Albert Beckers · Albert Beckers
Androgen receptor signaling pathways as a target for breast cancer treatment Elisabetta Pietri · Vincenza Conteduca · Daniele Andreis · Ilaria Massa · Elisabetta Melegari · Samanta Sarti · Lorenzo Cecconetto · Alessio Schirone · Sara Bravaccini · Patrizia Serra · Anna Fedeli · Roberta Maltoni · Dino Amadori · Ugo De Giorgi · Andrea Rocca · Andrea Rocca

65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine
Endocrine-Related Cancer | 2018
Ji Won Kim · Dharmendra K. Yadav · Soo Jin Kim · Moo-Yeol Lee · Jung-Min Park · Bum Seok Kim · Mi-hyun Kim · Hyeung-geun Park · Keon Wook Kang · Keon Wook Kang
Hyperglycemia decreases anti-cancer efficiency of Adriamycin via AMPK pathway
Endocrine-Related Cancer | 2018
Robert C. Mould · Jacob P. van Vloten · Amanda W. K. AuYeung · Khalil Karimi · Byram W. Bridle · Byram W. Bridle